Introduction {#s1}
============

Conditioned taste aversion (CTA) is a form of long-lasting aversive memory induced by a single pairing of exposure to an initially palatable taste with gastric malaise ([@bib8]). Although multiple brain regions, including the brainstem, amygdala and the cortex, participate in various aspects of taste behavior (reviewed in [@bib9]), prior work suggests that the basolateral amygdala (BLA) plays a critical role in CTA memory. Disrupting neuronal activity within the BLA blocks the formation and retrieval of CTA memory ([@bib85]; [@bib20]; [@bib23]; [@bib53]). This may reflect the fact that BLA projection neurons (BLApn) provide the principal output pathway from the amygdala to forebrain structures including the gustatory cortex and the central amygdala ([@bib16]) enabling it to distribute taste valance information to these regions ([@bib60]; [@bib68]). Consistent with this view, BLA neurons change their activity and their functional connectivity with their down-stream targets during CTA learning ([@bib25]). However, whether the BLA is a site of cellular and molecular plasticity during CTA learning, as opposed to merely gating plasticity in other structures, is not known.

Stages of memory formation are typically distinguished on the basis of duration and molecular mechanism. Short-term memory, lasting minutes to hours, requires only post-translational modification of preexisting proteins, whereas long-term memory, lasting days or longer, requires gene transcription and RNA translation, typically occurring in the hours following memory acquisition ([@bib50]; [@bib2]; [@bib22]; [@bib33]). Production of new proteins is required to produce lasting changes in the efficacy of synaptic connections and in the intrinsic excitability of neurons, which are thought to be the cellular correlates of memory ([@bib90]; [@bib55]). The cellular correlates of CTA learning are less completely understood than those of some other forms of learning, but the involvement of both synaptic plasticity ([@bib43]) and intrinsic plasticity ([@bib86]) have been demonstrated. CTA is known to require protein synthesis in the BLA ([@bib32]) and to increase the expression of the activity-dependent transcription factor C-FOS ([@bib81]). In other behavioral paradigms, neurons increasing C-FOS protein undergo changes in synaptic strength and intrinsic excitability ([@bib87]; [@bib65]; [@bib61]) and are thought to be essential parts of the neuronal network underlying long-term memory ([@bib79]). However, the role of neurons expressing C-FOS in the BLA during CTA is unclear. Also unknown is whether CTA learning requires new transcription, and if so, the identities of the required transcripts and cellular processes they promote are not known.

In this study, we found that new transcription in the BLA is required for CTA learning. Using RNA-seq from sorted neurons, we found that CTA changed the expression of many genes. In addition to the expected activation of *Fos*, expression of the kinase *Stk11*, also known as *Lkb1*, is altered following learning in BLA projection neurons (BLApn), but not in excitatory or inhibitory neurons within the GC. STK11 is known to act as a master regulator of growth, metabolism, survival and polarity by phosphorylating 13 down-stream members of the AMP-related kinase family ([@bib47]; [@bib70]). Recent work also suggests roles for STK11 in the nervous system, where it controls axonal specification and dynamics during development ([@bib7]; [@bib71]) and synaptic remodeling during old age ([@bib67]). STK11 can also regulate synaptic transmission in forebrain neurons ([@bib37]), but it has not previously been studied in the context of learning and memory or in the regulation of intrinsic neuronal excitability.

We find that *Stk11* is required for CTA since conditional knockout from BLApn prior to training impairs learning. However, the same deletion performed 2 days after training---that is, at a time when long-term memories have already been formed and stabilized---has no effect on subsequent memory retrieval. Deletion of *Stk11* also increased the excitability of BLApn, but did not alter the ability of the BLA-GC circuit to become transcriptionally activated by training or to encode the palatability of gustatory stimuli. CTA training is associated with an opposing decrease in intrinsic excitability in BLA projection neurons expressing C-FOS following learning. BLApn knockout of *Fos* also increased excitability and impaired learning, and expression of C-FOS and STK11 did not depend on each other. Thus, two independent genetic manipulations that affect learning also increase excitability. Using chemogenetics to independently increase BLApn excitability during CTA training without knocking out either gene also impaired CTA memory. Together, these data identify key roles for *Stk11* and *Fos* in CTA long-term memory formation and suggest they may act by convergently modulating the intrinsic excitability of BLApn.

Results {#s2}
=======

CTA long-term memory requires BLA transcription {#s2-1}
-----------------------------------------------

In order to determine whether CTA requires new RNA transcription within the BLA, we inhibited transcription by injecting Actinomycin-D (1 µl, 50 ng, bilaterally, [Figure 1](#fig1){ref-type="fig"}), a widely used RNA polymerase two inhibitor ([@bib2]), into the BLA 20 min prior to CTA training, and tested memory 48 hr later. As a control, a separate group of mice received vehicle injection (1 µl of PBS, bilaterally). CTA training consisted of 30 min of access to 0.5% saccharin followed by an intraperitoneal injection of 0.15M LiCl, 2% body weight; ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). A two-way mixed ANOVA comparing vehicle and actinomycin-D injected mice before and after training revealed a significant effect of treatment and a significant interaction between treatment and training ([Figure 1B](#fig1){ref-type="fig"}). Post-hoc analysis revealed significant reduction in the consumption of saccharin (CTA vs. Test) only for the vehicle group, indicating impairment of learning in the actinomycin-D treated mice. As a convergent measure, we also assessed the strength of CTA memory by calculating the relative consumption of saccharin during the test day to that consumed on the training day ([@bib58]). The differences between the groups (23% in the vehicle group vs. 80% for the actinomycin D group) were significant. Meanwhile, actinomycin-treated mice were neither impaired in their ability to detect the palatability of saccharin, nor in their drinking behavior---consumption of saccharin during CTA training was similar for the two groups, as was consumption of water 8 hr after the test ([Figure 1D](#fig1){ref-type="fig"}), suggesting that these nonspecific effects cannot account for the memory impairment. Thus, BLA transcription is essential for CTA memory formation. These results extend prior work showing the importance of BLA protein synthesis for CTA memory ([@bib32]) and together show that training induces both transcription and translation important for CTA in the BLA.

![Inhibiting BLA transcription impairs CTA Learning.\
(**A**) Protocol for injection (1 µl per hemisphere) of Actinomycin-D (50 ng) or vehicle (PBS with 0.02% DMSO). (**B**) Actinomycin D injection prior to CTA training impairs learning, expressed as a reduction in saccharin consumption between CTA and test sessions. Two-way mixed ANOVA revealed a significant effect of treatment and a significant interaction between training and treatment (treatment: F(1,10) = 9.99, p=0.010; training: F(1,10) = 4.62, p=0.057; interaction: F(1,10) = 5.237, p=0.045). Post hoc analysis (Bonferroni corrected) revealed significant reductions (p=0.001) of saccharin consumption (training vs. test) for vehicle treated, but not for actinomycin-D treated mice (p=0.94), and significant differences between the treatment groups during the test (p=7.1×10^−3^) but not during the training session (p=0.56). (**C**) Fraction of saccharin consumed (Test/CTA) was significantly higher (t(10)=-3.4; p=0.007) following Actinomycin D treatment than vehicle, consistent with weaker memory. (**D**) Treatments did not differ in water consumption measured 8 hr later (t(10)=0.28; p=0.79) suggesting this does not account for differences in consumption during the test. \*\*p\<0.01. (**E**) Guide cannula was coated with fluorescent dye to assess placement (Left) relative to desired location in anterior BLA (Right; bregma −1.4 mm; Allen brain atlas). Note that the injection cannula extended 0.5 mm further into the BLA. See also [Figure 1---source datas 1](#fig1sdata1){ref-type="supplementary-material"} and [2](#fig1sdata2){ref-type="supplementary-material"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.\
Figure 1---source data 1.Saccharin consumption (ml) during CTA training and test.This data relates to [Figure 1](#fig1){ref-type="fig"} panel B.\
Figure 1---source data 2.Fraction of saccharin consumed (Test/Training).This data relates to [Figure 1](#fig1){ref-type="fig"} panel C.](elife-61036-fig1){#fig1}

Transcripts regulated in BLA projection neurons following CTA {#s2-2}
-------------------------------------------------------------

In order to identify specific transcripts that might be necessary for CTA learning within the BLA, we used cell-type-specific RNA-seq to profile transcriptional changes in sorted BLA projection neurons (BLApn). We manually isolated fluorescently labeled BLApn neurons from YFP-H mice ([@bib19]) in which YFP is expressed under the Thy1 promoter in a large population of excitatory projection neurons located in the anterior part of the nucleus ([@bib76]; [@bib30]; [@bib52]). RNA sequencing was performed separately on YFP^+^ BLApn harvested 4 hr following training from mice undergoing CTA, and from taste-only controls (n = 4/group) ([Figure 2](#fig2){ref-type="fig"} and [Table 1](#table1){ref-type="table"}). A single control condition consisting of the taste stimulus without the unconditioned stimulus was used since our principal aim was identify target genes that could then be tested for causal roles in learning in subsequent behavioral experiments and since a prior study [@bib63] used a microarray screen following CTA to show that LiCl treatment (compared to taste control treatment) induced more than half of the same genes induced by CTA treatment (compared to taste control treatment).

![RNA sequencing from BLApn 4 hr following CTA training.\
(**A**) BLApn were isolated from YFP-H mice following CTA or taste control (N = 4/group). Neurons (150-200) were manually sorted form coronal slices (LA-lateral amygdala; CEA-central amygdala). Abundant transcripts (histogram, averaged across both groups) are enriched for those expected in the population and depleted for those expressed in other nearby populations ([Table 1](#table1){ref-type="table"}) including GABAergic interneurons, glia, or neurons in LA or CEA; [@bib76]; [@bib35]; Allen brain atlas). Glu- GABA-, glutamatergic, GABAergic neurons; AntBLA, PostBLA- Anterior and posterior portions of the BLA. TPM- transcript per million. (**B**) Among genes meeting robust criteria for differential expression (see [Table 1](#table1){ref-type="table"}) *Stk11* and *Fos* were selected for further analysis, including qPCR confirmation (**C**) in separate experiments (N = 4/group; \*p\<0.05). See also [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"} and [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"}--[4](#fig2s4){ref-type="fig"} and [Tables 1](#table1){ref-type="table"}--[3](#table3){ref-type="table"}.\
Figure 2---source data 1.qPCR validation for Fos and Stk11 mRNA expression in YFPH+ neurons.This data relates to [Figure 2](#fig2){ref-type="fig"}, panel C.](elife-61036-fig2){#fig2}

###### Transcripts in YFP^+^ BLApn with significantly altered expression 4 hr following CTA

Criteria: 2 ≤ Fold Change≤0.5, p\<0.01, TPM \>30 (TPM = transcript per million).

  Symbol                                  Fold- Change   P-Value   Gene name
  --------------------------------------- -------------- --------- -------------------------------------------------------------------
  Nptx1                                   2.02           1.57E-4   Neuronal pentraxin 1
  Ric8                                    2.06           0.0017    RIC8 guanine nucleotide exchange factor A
  Mmab                                    3.66           0.0019    Methylmalonic aciduria (cobalamin deficiency) cblB type homolog
  1110008F13Rik                           2.08           0.0028    RAB5 interacting factor
  Kbtbd4                                  2.09           0.0044    Kelch repeat and BTB (POZ) domain containing 4(Kbtbd4)
  Nudt21                                  2.14           0.0077    Nudix (nucleoside diphosphate linked moiety X)-type motif 21
  Fos                                     2.64           0.0094    FBJ osteosarcoma oncogene
  Magoh                                   2.72           0.0095    Mago homolog, exon junction complex core component
  Downregulated in CTA vs taste control                            
  Surf2                                   0.40           5.42E-4   Surfeit gene 2(Surf2)
  Tmem136                                 0.39           8.69E-4   Transmembrane protein 136
  Stk11                                   0.50           0.0011    Serine/threonine kinase 11(Stk11)
  Kank3                                   0.28           0.0022    KN motif and ankyrin repeat domains 3
  Lrrn1                                   0.49           0.0024    Leucine-rich repeat protein 1, neuronal
  Trpc1                                   0.48           0.0032    Transient receptor potential cation channel, subfamily C, memb. 1
  Prpf6                                   0.49           0.0045    Pre-mRNA splicing factor 6
  Tctex1d2                                0.49           0.0052    Tctex1 domain containing 2
  Gpr108                                  0.37           0.0056    G-protein-coupled receptor 108
  Vkorc1                                  0.39           0.0069    Vitamin K epoxide reductase complex, subunit 1
  D10Wsu102e                              0.50           0.0082    DNA segment, Chr 10, Wayne State University 102, expressed
  Tmem107                                 0.28           0.0089    Transmembrane protein 107

###### Transcripts in YFP^+^ L5 pyramidal neurons in the GC with significantly altered expression 4 hr following CTA

Criteria: 2 ≤ Fold Change≤0.5, p\<0.01, TPM \>30.

  Gene symbol   Fold-change   p-Value   Gene name
  ------------- ------------- --------- ------------------------------------------------
                                        Transcript Down-regulated CTA vs taste control
  Exosc1        0.43          0.008     Exosome component 1

###### Transcripts in Pvalb^+^ interneurons in the GC with significant altered expression 4 hr following CTA

Criteria: 2 ≤ Fold Change≤0.5, p\<0.01, TPM \>30.

  Symbol                                  Fold-change   p-Value   Gene name
  --------------------------------------- ------------- --------- -------------------------------------------------------------------------------
  Uprt                                    3.38          0.001     Uracil phosphoribosyltransferase
  Snca                                    2.66          0.001     Synuclein, alpha
  1810043H04Rik                           2.57          0.004     NADH:ubiquinone oxidoreductase complex Assemb.Fact. 8
  Dedd                                    2.47          0.001     Death effector domain-containing
  Fam149b                                 2.26          0.007     Family with sequence similarity 149, member B
  Jazf1                                   2.12          0.008     JAZF zinc finger 1
  Nup54                                   2.09          0.007     Nucleoporin 54
  Downregulated in CTA vs taste control                           
  Dear1                                   0.006         0.0006    Dual endothelin 1/angiotensin II receptor 1
  Nt5c3b                                  0.20          0.002     5\'-nucleotidase, cytosolic IIIB
  Lrrc16b                                 0.26          0.010     Capping protein regulator and myosin 1 linker 3
  Enc1                                    0.31          0.005     Ectodermal-neural cortex 1
  Asap2                                   0.38          0.004     ArfGAP with SH3 domain, ankyrin repeat and PH domain 2
  Pacs2                                   0.38          2E-4      Phosphofurin acidic cluster sorting protein 2
  Ncan                                    0.42          0.008     Neurocan
  uc008jhl.1                              0.42          0.010     
  Smarcd3                                 0.45          0.006     SWI/SNF Related, Matrix Assoc.Actin Dep.Reg. Chromatin, Subfamily D, Member 3
  Tbce                                    0.46          0.002     Tubulin-specific chaperone E
  uc009mzt.1                              0.47          0.008     
  Anxa6                                   0.50          0.001     Annexin A6

Sequencing results ([Figure 2A](#fig2){ref-type="fig"}) also confirmed the purity and molecular identity of YFP-H neurons in the BLA, as transcripts known to be expressed in BLApn and other forebrain excitatory projection neurons were enriched and transcripts known to be expressed in inhibitory interneurons, glia cells and other neurons in the vicinity of the BLA (lateral amygdala or central amygdala) were virtually absent. Moreover, this observed pattern of expression was comparable to that reported in other studies profiling the same population ([@bib76]; [@bib52]).

CTA training changed expression of many genes. [Table 1](#table1){ref-type="table"} lists the 20 transcripts showing differential expression between CTA and taste control group based on robust expression criteria: 2 ≤ fold change≤0.5, p\<0.01 (unpaired t-test), transcripts-per-million (TPM) ≥30. Included among these transcripts is the activity-dependent transcription factor, *Fos* which has previously been shown to be upregulated in BLApn following CTA and other learning paradigms ([@bib89]; [@bib85]; [@bib51]; [@bib81]). *Fos* is an activity-dependent transcription factor that controls the transcription of downstream targets, which are capable of changing neuronal physiology ([@bib49]). Among these, YFP^+^ BLApn, express Nptx2, a member of the pentraxin family involved in AMPA receptor clustering ([@bib11]). Our sequencing results revealed a two-fold increase of Nptx2 levels following CTA (fold-change = 2.1; p=0.029; N = 4/group, unpaired t --test), which was further validated by qPCR in separate experiments (Fold-change = 2.4; p=0.028; N = 4/group; [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}).

Our screen for differentially expressed genes also identified *Stk11* (also known as *Lkb1*; [Figure 2B](#fig2){ref-type="fig"}) a kinase well studied in the contexts of cancer, cell growth and development, but not previously studied in the contexts of learning and neuronal plasticity ([@bib6]; [@bib3]; [@bib7]; [@bib26]; [@bib14]). Changes in the expression of both *Fos* and *Stk11* were validated by qPCR in separate experiments, which revealed a 4.6-fold increase in *Fos* mRNA (t(6)=2.5; p=0.045) and a 1.9-fold decrease in *Stk11* (t(6)=-2.5; p=0.046) ([Figure 2C](#fig2){ref-type="fig"}). To further examine the significance of these transcriptional changes, we also analyzed the levels of FOS and STK11 protein in the BLA. The fraction of C-FOS-expressing YFP-H neurons in the BLA 4 hr following CTA was significantly increased relative to lithium chloride-only and taste-only control groups ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). We measured STK11 4 hr following CTA or presentation of taste alone, by performing immunoblotting of proteins isolated from the anterior BLA. Surprisingly, we found a 1.8-fold increase ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}) indicating that protein and mRNA expression are regulated in opposite directions at this time point.

STK11 is at the apex of the AMP-related kinase pathway and mediates its effects by phosphorylating one or more of 13 different downstream kinases, all of which share some homology with AMP-kinase ([@bib47]; [@bib70]). Among these, YFP^+^ BLApn had moderate expression of *Brsk2* (TPM = 39.9) and *Mark2/3* (TPM = 59.3 and 73.7 respectively; [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}), which have known roles in establishing cell polarity during neuronal development ([@bib7]; [@bib70]). Expression of AMP kinase itself (*Prkaa1/2*), an important metabolic regulator in many cell types ([@bib70]) was lower (TPM = 16.4 and 22.3, respectively). Comparing kinase expression between CTA and control groups revealed nearly two-fold less expression of *Mark2* following CTA (fold-change = 0.41; p=0.04, unpaired t-test; data not shown), but this was not significant after Bonferroni correction across the compared kinases.

We also analyzed the impact of CTA on the transcriptional profile of layer five pyramidal neurons labeled in strain YFP-H and Pvalb-expressing inhibitory interneurons in the GC, a brain region in which transcription is also known to be important for CTA learning ([@bib29]). RNA sequencing was performed on YFP^+^ and Pvalb+ neurons in the GC harvested from mice 4 hr following CTA training, and from taste-only controls (n = 3/4/group). [Tables 2](#table2){ref-type="table"} and [3](#table3){ref-type="table"} list the transcripts showing the most differentially expressed genes using the same criteria used in the BLA: 2 ≤ fold change≤0.5, p\<0.01 (unpaired t-test), transcripts-per-million (TPM) ≥30. While Pvalb+ neurons showed a robust transcriptional response, evident by 19 genes reaching the criteria, only one gene reached the same criteria in YFP+, suggesting a weaker CTA-driven transcriptional response in these neurons. Importantly, the expression of *Fos* and *Stk11* in both YFP+ and Pvalb+ neurons, did not differ between CTA and control groups ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"} and [Tables 2](#table2){ref-type="table"} and [3](#table3){ref-type="table"}). This suggests that the differential expression of *Fos* and *Stk11* during CTA learning may be specific to a subset of cell-types within the circuit.

*Fos* and *Stk11* expression in BLA projection neurons are necessary for memory formation {#s2-3}
-----------------------------------------------------------------------------------------

We next wished to determine whether any of the transcriptional changes in BLApns that correlate with learning are indeed necessary for learning to occur. Since both C-FOS and STK11 protein increase following CTA, we pursued a loss-of-function (LOF) strategy. To restrict LOF to BLApns, we performed conditional deletion by injecting Cre recombinase into mice carrying alleles of *Fos* ([@bib89]) or *Stk11*([@bib57]) in which key exons are flanked by lox-p sites. In both cases, recombination leads to a functionally null allele and analyses were carried out in homozygous (^f/f^) animals. Cre was delivered by injecting AAV2/5-Camk2α::Cre-GFP into the BLA bilaterally. As expected, this led to GFP expression in excitatory projection neurons, but not in BLA interneurons or adjacent GABAergic neurons in the Central Amygdala (CEA; [Figure 3](#fig3){ref-type="fig"}, 5). Animals carrying the same genotypes but receiving AAV2/5-Camk2α::GFP served as controls. Injections were performed 10 days prior to analysis to allow time for LOF to occur.

![Deletion of *Fos* from BLApn reduces the strength of learning.\
(**A,B**) BLA of *Fos*^f/f^ mice were infected with viruses expressing Cre-GFP (**B**) or GFP alone (**A**). C-FOS induction was tested 10 days later, 4 hr after onset of seizures in response to kainic acid (20 mg/kg). Cre injected BLA's had reduced C-FOS expression confirming penetrance of the knock-out. (**C--E**) Fos deletion from BLApn attenuates CTA learning. *Fos* f/f mice received Cre and control viruses bilaterally and were trained for CTA 10 days later and then tested after an additional 48 hr. (**C**) Both groups exhibited significant memory reflected by reduced saccharin consumption between training and testing sessions. Mixed ANOVA revealed a significant effect of training (F(1,14) = 154.6, p=5.9×10^−9^), but not of knockout (F(1,14) = 0.15, p=0.70), although there was a significant interaction (F(1,14) = 9.67, p=0.008). Post-hoc analysis revealed that both GFP (N = 8) and Cre (N = 8) group reductions following CTA (test vs. train) were significant (GFP: p=9×10^−6^; Cre: p=3.6×10^−4^) but differences between the other conditions were not (CTA-GFP vs CTA-Cre: p=0.26 and test-GFP vs test-Cre: p=0.065). (**D**) *Fos* deletion from BLApn reduced memory strength measured as the fraction of saccharin consumed (test/training): 25% (GFP) versus 49% (Cre) and this difference in ratios was significant (t(14)=-2.7; p=0.017). (**E**) Reduced saccharin consumption cannot be attributed to overall inhibition of drinking as the amount of water drunk 8 hr later did not differ (p=0.26). \*p\<0.05; \*\*p\<0.01. See also [Figure 3---source datas 1](#fig3sdata1){ref-type="supplementary-material"} and [2](#fig3sdata2){ref-type="supplementary-material"}.\
Figure 3---source data 1.Saccharin consumption (ml) during CTA training and test.This data relates to [Figure 3](#fig3){ref-type="fig"}, panel C.\
Figure 3---source data 2.Fraction of saccharin consumed (Test/Training).This data relates to [Figure 3](#fig3){ref-type="fig"} panel D.](elife-61036-fig3){#fig3}

To assess the efficacy of this approach for CTA learning, we first examined the necessity of *Fos* expression. *Fos* is known to contribute to multiple forms of learning and plasticity ([@bib89]; [@bib79]) and has previously been implicated in CTA ([@bib38]; [@bib85]). To first confirm effective Cre-mediated recombination, we tested the ability of viral Cre to prevent widespread C-FOS expression in the BLA immediately following kainic-acid-induced seizures. C-FOS staining performed four hours after seizures revealed strong induction throughout the BLA of control mice injected with the control virus, and diminished C-FOS expression in mice injected with Cre ([Figure 3A,B](#fig3){ref-type="fig"}). We then tested the effect of *Fos* deletion on CTA in separate animals. Cre-GFP and GFP control AAV's were injected into the BLA of *Fos*^f/f^ mice, CTA training occurred 10 days later, and long-term memory was tested after an additional 2 days.

The results show that while both groups could form CTA memory, Cre injected mice showed significantly weaker memory ([Figure 3C--E](#fig3){ref-type="fig"}). This confirms our ability to manipulate memory by conditional knockout in BLApn neurons. The results refine those of a prior study using antisense injections and germline knockouts ([@bib85]).

Next, we used the same strategy to test the necessity of *Stk11* expression in BLApn for CTA memory. BLA of *Stk11^f^*^/f^ mice were injected bilaterally with AAV expressing Cre- GFP, or GFP alone. Ten days later, both groups of mice were trained for CTA and tested after an additional 2 days. The results revealed a near complete loss of learning in the *Stk11* KO mice ([Figure 4A,B](#fig4){ref-type="fig"}), which exhibited no significant reduction in the amount or ratio of saccharin consumed after training. Control mice exhibited significant reductions consistent with a similar degree of learning to that seen in previous control experiments. The differences in the consumption of saccharin during the test day were not attributable to overall reduced drinking, as both group of animals consumed comparable amounts of water 8 hr later ([Figure 4C](#fig4){ref-type="fig"}). Taken together, these results indicate that *Stk11* expression in BLApn is essential for CTA memory.

![Deletion of Stk11 from BLApn impairs CTA learning.\
(**A**) *Stk11*^f/f^ mice were infected with Cre or control viruses 10 days before CTA training and were tested 48 hr later. Despite significant reduction in saccharin consumption between testing and training sessions in control mice, *Stk11* KO animals showed almost no learning. Mixed ANOVA revealed significant training and genotype effects (training: F(1,11) = 42.1; p=4.5×10^−5^; genotype: F(1,11) = 18.2; p=0.001; as well as a significant interaction: F(1,11) = 9.2, p=0.012). Post-hoc analysis (Bonferroni corrected) revealed that although both GFP (N = 6) and Cre (N = 7) reductions following CTA (test vs. train) were significant (GFP: p=0.003; Cre: 0.013), there was a large and significant difference in saccharin consumption between GFP and Cre groups during the test (GFP: 0.25 ml; Cre: 0.75 ml; p=2.1×10^−4^), while differences in saccharin consumption during training were not significant (p=0.15). (**B**) Control animals (GFP) consumed only 33% of the training amount during the test, but KO mice (Cre) consumed 78% and this difference was significant (t(11)=-4.91; p=4×10^−4^). (**C**) Reduced saccharin consumption does not reflect an overall reduction in drinking measured 8 hr later (t(11)=0.25; p=0.87). \*\*p\<0.01. (**D**) *Stk11* deletion after long-term memory formation has no effect on CTA retention. *Stk11* f/f mice received Cre and control viruses 2 days after CTA training and were tested 10 days later. Mixed ANOVA revealed a significant effect of training (F(1,11) = 48.8, p=2.3×10^−5^) but no significant effect of genotype (F(1,11) = 1.7, p=0.23) or interaction (F(1,11) = 0.76, p=0.40). Post-hoc analysis confirmed significant reductions in both groups following CTA (GFP: N = 7, p=0.003. Cre: N = 6, p=0.002). There was no significant difference between GFP and Cre groups during training (p=0.19) or during the test (p=0.64). (**E**) There was no significant difference in CTA intensity as measured by the fraction of saccharin consumed (t = −0.18, p=0.86). \*\*p\<0.01. See also [Figure 4---source datas 1](#fig4sdata1){ref-type="supplementary-material"}--[4](#fig4sdata4){ref-type="supplementary-material"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}.\
Figure 4---source data 1.Saccharin consumption (ml) during CTA training and test.This data relates to [Figure 4](#fig4){ref-type="fig"} panel A.\
Figure 4---source data 2.Fraction of saccharin consumed (Test/Training).This data relates to [Figure 4](#fig4){ref-type="fig"} panel B.\
Figure 4---source data 3.Saccharin consumption (ml) during CTA training and test.This data relates to [Figure 4](#fig4){ref-type="fig"} panel D.\
Figure 4---source data 4.Fraction of saccharin consumed (Test/Training).This data relates to [Figure 4](#fig4){ref-type="fig"} panel E.](elife-61036-fig4){#fig4}

*Stk11* deletion prior to CTA training can potentially alter multiple memory stages including memory formation and retrieval ([@bib39]; [@bib40]). Because CTA memory is long-lasting after even a single training session, it is possible to distinguish an effect of *Stk11* deletion on memory formation from an effect on retrieval by performing the deletion figure supplement 1). Both Cre-GFP and GFP injected mice developed CTA ([Figure 4D](#fig4){ref-type="fig"}) -- there was no significant between-group difference in the intensity of memory, assessed from the ratio of saccharin consumed during the test ([Figure 4E](#fig4){ref-type="fig"}). Since the same deletion produces a profound effect when occurring prior to training, this suggests that deletion of Stk11 from BLApn does not affect the retention and retrieval of CTA memory, provided memory was already formed prior to performing the knockout. This argues that Stk11 is required for CTA memory formation.

The fact that the expression of both *Fos* and *Stk11* in BLApn are needed for normal CTA long-term memory raises the question of their possible interaction. To address this question, we first examined the expression of C-FOS 4 hr following CTA training in *Stk11*^f/f^ mice receiving Cre or control virus injection 10 days earlier. There was no difference between the control and knockout groups (t(4)=-0.42; p=0.69, N = 3/group. [Figure 5---figure supplement 1a](#fig5s1){ref-type="fig"}). In a complementary experiment, we examined the expression of STK11 4 hr following CTA in Fos^f/f^ mice receiving Cre or control virus injection 10 days earlier. We also found no significant difference between the control and knockout groups in this experiment (t(4)=0.028; p=0.84, N = 3/group. [Figure 5---figure supplement 1b](#fig5s1){ref-type="fig"}). Thus, the expression of *Stk11* or *Fos* is not dependent upon the expression of the other, and they likely represent signaling pathways that are at least initially separate.

*Stk11* deletion in BLApn does not impact taste palatability coding in the GC {#s2-4}
-----------------------------------------------------------------------------

Since Stk11 deletion must occur prior to CTA training to have an effect on learning, we needed to rule out the possibility that its effect on memory came via disruption of either the responsiveness of BLA neurons to training stimuli, or the output of BLA neurons, which is known to be required for palatability coding within GC.

A more rigorous test of BLA function is to determine whether palatability coding in the GC is intact following knockout, since this is known to depend on intact output from the BLA ([@bib60]; [@bib68]; [@bib46]; [@bib44]). If *Stk11* deletion disrupts gustatory activation of BLApn or their output to the GC, palatability coding recorded in the GC should be impaired. To test this, *Stk11* deletion in BLApn was performed as before and 10 days later multi-channel in vivo recordings of GC taste responses were obtained. Recordings were targeted to the ventral part of GC, since BLA projects to these regions ([Figure 5A](#fig5){ref-type="fig"}; [@bib48]; [@bib27]; [@bib41]). Palatability coding was assessed with a battery of four tastes with hedonic values ranging from palatable (sucrose and sodium-chloride) to aversive (citric-acid and quinine; for details see [@bib41]).

![*Stk11* deletion in BLApn does not affect taste palatability coding in the GC.\
(**A**) The BLA of *Stk11*^f/f^ mice was infected bilaterally with Cre or control viruses. The ventral GC, where BLA projections terminate ([@bib27]) was implanted with a multi-electrode array 10 days later to record GC taste responses to a battery of four tastes differing in their hedonic value, the palatable sucrose and sodium-chloride and the aversive critic acid and quinine ([@bib41]). Images show BLA injection site (left) and labeled BLA terminals in the ventral GC co-localized with the site of dye-labeled electrodes (right). (**B**) PSTHs (colored lines) from a representative GC neuron in a GFP-injected control mouse that responded significantly to all tastes. Dashed line represents the magnitude of the rank correlation between firing rates and behaviorally measured palatability obtained previously in separate experiments ([@bib41]). (**C**) Correlation coefficients averaged across all recorded units in GFP (control) and Cre-injected mice. As revealed in a two-way ANOVA, palatability correlations in both groups rise steeply between 800 and 1000 ms with no significant difference between genotypes (F(1,133)=0.13, p=0.72) or interaction (p=0.99). See also [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}.](elife-61036-fig5){#fig5}

[Figure 5](#fig5){ref-type="fig"} shows the results of GC taste responses following *Stk11* deletions in BLA. [Figure 5B](#fig5){ref-type="fig"} illustrates the peri-stimulus histogram of a representative GC neuron responding to the taste battery. As observed previously in rats and mice ([@bib34]; [@bib66]; [@bib41]), different aspects of taste processing are encoded in firing rates sequentially. In the first five hundred milliseconds or so post-taste delivery, neurons show different firing rates to different tastes (i.e. reflecting taste identity coding), while later in the responses, differential response rates reflect the hedonic values of tastes (i.e. taste palatability coding). These properties were maintained in the mice studied here: as indicated by the dashed line, the magnitude of the correlation between the neuron's stimulus evoked firing rates and the behaviorally determined palatability ranking rose significantly only after the first half a second following taste delivery. The averaged correlation magnitudes across neurons from Cre and GFP injected mice are shown in [Figure 5C](#fig5){ref-type="fig"}. Inspection of the figure suggests that BLA *Stk11* deletion had little effects on GC taste palatability coding; the correlations in both GFP- and Cre-injected groups rise around half a second and peaks at about one second after taste delivery. An ANOVA found no significant group differences across each time bin, suggesting that *Stk11* deletion in BLA has little detectable influence on GC taste processing.

Taken together, our molecular and electrophysiological analyses suggest that the memory deficit observed after Stk11 deletion is unlikely to be due to a deficit in basic taste processing. Rather, Stk11 deletion likely impairs memory by affecting the process of memory formation.

*Stk11* and *Fos* deletion increase the intrinsic excitability of BLApn, while CTA decreases excitability {#s2-5}
---------------------------------------------------------------------------------------------------------

What cellular mechanisms mediate the effects of *Fos* and *Stk11* on memory formation? Long-term memory is known to be accompanied by changes in both the intrinsic excitability of neurons ([@bib90]; [@bib55]) and in the strength of their synaptic connections. Recent studies have shown that the intrinsic excitability of BLApn can be modulated bi-directionally during reinforcement learning, with positive reinforcement leading to increased and negative reinforcement to decreased intrinsic excitability ([@bib54]).

To determine whether *Stk11* might influence memory formation by altering intrinsic excitability, we compared the excitability of BLApn recorded in ex vivo slices from mutant animals receiving Cre-GFP ([Figure 6](#fig6){ref-type="fig"}). The results reveal a marked increase in the intrinsic excitability of BLApn following deletion of *Stk11*, relative to GFP-only controls. Cre infected neurons had higher firing rates than GFP neurons for any given amount of current input resulting in a steeper slope of the firing rate vs. current (F-I) curve. Threshold firing was initiated at a lower level of current injection (i.e. the rheobase was lower; [Figure 6C](#fig6){ref-type="fig"}). This reflected a higher resting input resistance and a slightly lower voltage threshold. Some other electrophysiological properties also differed (see [Table 4](#table4){ref-type="table"}) including sag ratios, action potential amplitudes, and the medium and slow afterhyperpolarizations, while others, such as the degree of firing rate accommodation, spike widths and resting membrane potentials did not. Thus, *Stk11* deletion from BLApn neurons increases overall intrinsic excitability, most likely by affecting multiple biophysical properties of these neurons.

![*Stk11* deletion in BLApn increases intrinsic excitability.\
(**A**) Whole-cell recordings obtained from BLApn in ex vivo slices of *Stk11*^f/f^ mice 10 days after injection of Cre or control virus. *Stk11* neurons were targeted based on GFP expression and validated post-hoc based on Biocytin fills. (**B**) Firing rates plotted against input current (F--I). Error bars are SEM. Less current is needed to evoke firing in *Stk11*-KO neurons compared to *Stk11*-WT neurons (interpolated rheobase, F(1,64) = 10.6, p=0.0018). Two-way mixed ANOVA revealed significant main effects of knockout (F(1,64) = 27.48, p=2×10^−6^) and current (F(10,640) = 581.7, p=1.2×10^−44^) on firing rate, along with a statistically significant interaction (F(10,640) = 22.4, p=4×10^−36^). Post-hoc pairwise comparisons showed that the firing rates of *Stk11*-KO neurons were significantly greater than those of *Stk11*-WT neurons in response to current injections from 150 to 450 pA (p\<0.001). (**C**) *Stk11*-KO neurons have increased input resistance (F = 14.41, p=3.3×10^−4^) and decreased threshold for generating action potential (F = 7.68, p=0.0073). Traces are sample responses to 300 pA current steps. Scale bar: 100 ms, 20 mV. See also [Table 4](#table4){ref-type="table"}.](elife-61036-fig6){#fig6}

###### Electrophysiological properties of BLApn: *Stk11* knockout vs. GFP controls

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Group         Statistics   Resting membrane\   Access resistance\   Input resistance\   mAHP (mV)   sAHP (mV)   Action potential\   Action potential\   Action potential\   Sag ratio
                             potential (mV)      (mΩ)                 (mΩ)                                        amplitude (mV)      half width (ms)     threshold (mV)      
  ------------- ------------ ------------------- -------------------- ------------------- ----------- ----------- ------------------- ------------------- ------------------- -----------
  KO\           Mean         −78.23              19.68                105.33              7.44        0.92        74.41               0.80                −50.01              0.13
  Mice = 11\                                                                                                                                                                  
  Neuron = 30                                                                                                                                                                 

  S.D.          3.73         2.76                24.88                1.93                0.35        6.58        0.10                2.44                0.04                

  GFP\          Mean         −76.96              18.02                85.41               9.71        0.64        78.05               0.79                −48.30              0.15
  Mice = 11\                                                                                                                                                                  
  Neuron = 36                                                                                                                                                                 

  S.D.          2.66         3.47                17.65                1.64                0.26        4.39        0.07                2.55                0.03                

                F            2.59                4.47                 14.41               26.69       13.78       7.17                0.19                7.68                7.48

  p             0.112        0.0383              3.29E-4              2.54E-06            4.32E-4     0.0094      0.664               0.0073              0.008               
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Since *Stk11* and *Fos* deletion both impair CTA learning, we wondered whether *Fos* deletion also increases the intrinsic excitability of BLApn. Analysis of *Fos* KO neurons revealed a similar increase in firing relative to control neurons (N for: WT = 14, KO = 22; [Figure 7A--B](#fig7){ref-type="fig"}). Two-way ANOVA indicated a significant effect of genotype (in addition to the expected effect of current level). Significant differences in input resistance and action potential threshold were also detected.Next, we asked whether we could detect an effect of learning itself on neuronal excitability in the BLA. A difficulty with this experiment is that learning may have different effects on different populations of BLApn as evidenced by the fact that some neurons increase C-FOS expression following training, while others do not ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). In order to separately examine these two populations following training, we made use of the reporter system developed by Reijmers and colleagues, in which elements of the *Fos* promoter are used to drive the tet transactivator (tTA) which can then prolong and amplify expression of a reporter marking *Fos*-activated cells, when Doxycycline (Dox) is absent ([@bib64]). In this case, we provided the tet-dependent reporter via an AAV (TRE::mCherry) injected into the BLA 10 days prior to training. Animals were fed Dox until 24 hr prior to training to limit background activation ([Figure 7C](#fig7){ref-type="fig"}). Control experiments showed that CTA training resulted in a greater number of neurons expressing *Fos* 24 hr after training, compared to home cage controls ([Figure 7D](#fig7){ref-type="fig"}). Twenty-four hours following CTA training or taste-only control experiments, recordings were obtained from BLApn in acute slices. Two-way ANOVA revealed that BLApn in the CTA animals have lower input resistance than those in control animals and that *Fos*-activated neurons have lower input resistance than unlabeled neurons ([Figure 7E](#fig7){ref-type="fig"}). Notably, this change is in the opposite direction from that produced by deletions of *Stk11* and *Fos*, two manipulations that impair learning. This suggests that these mutations may interfere with learning by impairing changes in intrinsic excitability that are required for learning to occur.

![*Fos* deletion and CTA have opposing effects on resting input resistance.\
(**A,B**) Whole-cell patch clamp recordings obtained from BLApn in ex vivo slices of *Fos*^f/f^ mice 10 days after injection of Cre or control virus. *Fos*-KO neurons exhibit increased firing in response to current injection compared to *Fos*-WT neurons. (**A**) Average frequency-current (FI) curves. Two-way mixed ANOVA revealed a significant main effect of knockout (F(1,49) = 8.79, p=0.005) and current (F(9,441) = 419.4, p=6×10^−210^) on firing rate, along with a statistically significant interaction (F(9,441) = 8.2, p=2.57×10^−11^). Post-hoc pairwise comparisons showed that the firing rates of *Fos*-KO neurons were significantly greater than those of *Fos*-WT neurons in response to current injections from 150 to 450 pA (p\<0.05). (**B**) Differences in input resistance (F(1) = 10.62, p=0.0025) and action potential threshold (F(1) = 6.82, p=0.013) between *Fos*-KO and *Fos*-WT neurons were also significant. Traces show sample responses to 250 pA current steps. Scale bar: 100 ms, 20 mV. (**C**) Tet-dependent labeling of *Fos* expressing neurons ([@bib64]) during CTA training. Fos::tTa mice injected with AAV-TRE::mCherry received food with 40 ppm Doxycycline (Dox) to suppress reporter expression. One day prior to CTA training, Dox was removed. Acute slices were prepared 24 hr following CTA (Saccharin+lithium) or control (Saccharin+saline) training. (**D**) MCherry labeled neurons in the BLA. (**E**) Input resistances of *Fos*^+/-^ neurons in the BLA, following CTA training and taste-only control experiments. Two-way ANOVA reveals that neurons from CTA animals have lower input resistance than those from control animals (F(1,65) = 10.26, p=0.0021) and that *Fos*^+^ neurons have lower input resistance than *Fos*^-^ neurons (F(1,65) = 23.64, p=7.5×10^−6^). Post-hoc tests show that among *Fos*^+^ neurons, those in CTA animals have lower input resistance (p=0.015), while among *Fos*^-^ neurons, there was no significant difference between CTA and control animals (p=0.1). Differences between *Fos*^+^ and *Fos*^-^ neurons did not reach post-hoc significance in either the CTA (p=0.25) or control animals (p=0.12) considered alone. See also [Table 5](#table5){ref-type="table"}.](elife-61036-fig7){#fig7}

###### Electrophysiological properties of BLApn: *Fos* knockout vs. GFP controls

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Group         Statistics   Resting membrane\   Access\           Input\            mAHP (mV)   sAHP (mV)   Action potential\   Action potential\   Action potential\
                             potential (mV)      resistance (mΩ)   resistance (mΩ)                           amplitude (mV)      half width (ms)     threshold (mV)
  ------------- ------------ ------------------- ----------------- ----------------- ----------- ----------- ------------------- ------------------- -------------------
  KO\           Mean         −75.43              19.63             113.91            10.34       0.40        65.87               0.72                −40.79
  Mice = 5\                                                                                                                                          
  Neuron = 27                                                                                                                                        

  S.D.          5.08         4.95                27.73             4.30              0.19        8.31        0.11                5.83                

  GFP\          Mean         −76.50              14.35             86.01             8.95        0.38        73.30               0.74                −45.62
  Mice = 5\                                                                                                                                          
  Neuron = 24                                                                                                                                        

  S.D.          3.38         5.17                19.58             2.05              0.17        5.11        0.12                3.02                

                F            0.768               13.882            16.812            2.096       0.144       14.334              0.224               13.306

  p             0.385        5.04E-04            1.55E-04          0.154             0.706       4.18E-04    0.638               6.40E-04            
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------

To more directly test the hypothesis that changes in intrinsic excitability of BLApn play a key role in the formation of CTA memory, we virally expressed the excitatory DREADD (Designer Receptors Exclusively Activated by Designer Drugs) hM3Dq and then transiently increased the intrinsic excitability of BLApn during memory formation. hM3Dq is a Gq-coupled muscarinic receptor containing a modified binding site permitting activation by the synthetic ligand CNO (Clozapine-N-Oxide) but not by endogenous ligands ([@bib4]). Whole-cell patch clamp recordings in acute brain slices from BLApn infected in vivo with AAV-Camk2α::hM3Dq confirmed the ability of CNO to increase their intrinsic excitability (8-figure supplement 1 A-C: higher firing rate for CNO conditions compared to control with 100 pA current input, paired sample t-test, t = −4.73, p=1×10^−4^; Resting membrane potentials of neurons are significantly higher in CNO conditions than in control (paired sample t-test, t = −8.52, p=2×10^−8^). In addition, we confirmed that systemic injection of 0.3 mg/kg CNO to mice infected with Camk2α::hM3Dq increased C-FOS expression 60 min later ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Mice infected with Camk2α::hM3Dq/GFP were then trained for CTA 60 min after systemic injection of 0.3 mg/kg CNO and were tested 48 hr later. We found that while both groups of mice developed CTA reflected by significantly reduced saccharin consumption, hM3Dq-injected mice consumed more saccharin during the test then mice receiving the control GFP virus, but did not differ in their consumption of saccharin during training in comparison to GFP injected mice ([Figure 8A](#fig8){ref-type="fig"}) resulting in significantly stronger CTA ([Figure 8B](#fig8){ref-type="fig"}). These data show that increasing excitability during CTA training impairs CTA memory formation. Together with our previous data, this suggests that that *Stk11* and *Fos* expression play key roles in CTA long-term memory formation, by modulating the intrinsic excitability of BLApn.

![Increasing excitability using hM3Dq DREADD in BLApn during CTA training impairs CTA learning.\
*Stk11*^f/f^ mice were infected with Camk2α::hM3Dq or Camk2α::GFP control viruses 10 days before CTA training. Mice received systemic CNO (0.3 mg/kg) 60 min before training and were tested for CTA memory 48 hr later. (**A**) Control mice had greater reductions in saccharin consumption between testing and training sessions than hM3Dq mice. Mixed two-way ANOVA revealed a significant training effect and a significant interaction between training and treatment (training: F(1,16) = 32.6, p=3.2×10^−5^; treatment: F(1,16) = 0.63, p=0.44; interaction: F(1,16) = 8.97, p=0.009). This indicates that the effect of training depends on the treatment condition. Post hoc analysis revealed that although both GFP injected mice (N = 8) and hM3Dq injected mice (N = 9) developed CTA indicated by reduced saccharin consumption (GFP: p=0.001; hM3Dq: p=0.019), hM3Dq injected mice drank significantly more saccharin during the test then GFP mice (p=0.005). There was no significant difference in the consumption of saccharin during training (p=0.227). (**B**) The strength of CTA learning was expressed as the fraction of saccharin consumed between testing and training. GFP controls consumed only 22% during the test, relative to training, but hM3Dq mice consumed 72% and this difference was significant (t(15)=3.96; p=0.001). \*p\<0.05, \*\*p\<0.01. See also [Figure 8---source datas 1](#fig8sdata1){ref-type="supplementary-material"}--[2](#fig8sdata2){ref-type="supplementary-material"} and [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}.\
Figure 8---source data 1.Saccharin consumption (ml) during CTA training and test.This data relates to [Figure 8](#fig8){ref-type="fig"} panel A.\
Figure 8---source data 2.Fraction of saccharin consumed (Test/Training).This data relates to [Figure 8](#fig8){ref-type="fig"} panel B.](elife-61036-fig8){#fig8}

Discussion {#s3}
==========

This study is the first to identify a role for Stk11, a master kinase at the top of the AMP-related kinase pathway, in long-term memory. Using CTA as a behavioral paradigm, we first established a causal requirement for transcription in BLApn during establishment of long-term memory, and went on to show that changes in *Stk11* and *Fos* transcription and translation accompany CTA learning. Cell-type-specific conditional knock-out of *Stk11* in BLApn revealed it to be necessary for CTA memory formation but not for retrieval, once memories were established. Slice recordings revealed that *Stk11* modulated the intrinsic excitability of these neurons and further investigations suggested the general importance of excitability changes for memory---deletion of the immediate early gene *Fos* in BLApn altered excitability similarly to *Stk11* deletion, and conversely activation of *Fos* during learning reduced excitability. Finally, a transient chemogenetic increase in BLApn excitability during CTA training also impaired CTA memory. This suggests a model in which *Stk11* and *Fos* expression plays important role in CTA long-term memory formation by modulating the intrinsic excitability of BLApn.

BLA projection neurons undergo transcription important for CTA learning {#s3-1}
-----------------------------------------------------------------------

It is well established that BLA neurons play a necessary role in CTA learning. Multiple studies confirm that activity in the BLA is required for memory formation and retrieval ([@bib20]; [@bib23]; [@bib53]). CTA also requires protein synthesis in the BLA ([@bib32]), but whether new transcription is also required, and if so, the identities of the required transcripts and the cellular processes they promote were not previously known.

Here, we show that BLA projection neurons (BLApn) undergo transcriptional changes important for CTA memory. Inhibiting transcription during CTA training impairs memory tested 48 hr later. Using cell-type-specific RNA sequencing, we go beyond this simple insight to identify the transcripts that are altered in expression in BLApn four hours after pairing of the conditioned and unconditioned stimuli. For comparison, we also examined changes in transcript levels in pyramidal neurons and parvalbumin-positive interneurons in gustatory cortex. These profiling experiments provide a resource for future investigations of other molecules potentially involved in CTA in BLA and GC.

Perhaps the strongest case for new transcription in BLApn involved in learning can be made for the immediate early gene Fos. It is well known that Fos transcription and translation are activated in the forebrain by a variety of memory paradigms ([@bib51]), and more specifically by CTA in BLApn ([@bib81]). The YFP-H neurons studied here include the majority of BLApn in the anterior portion of the nucleus ([@bib19]; [@bib76]; [@bib30]; [@bib52]) and the fact that many of these neurons express Fos protein ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) and project to GC ([Figure 5A](#fig5){ref-type="fig"} and [@bib27]) supports the suggestion that they are among the population of BLApn transcriptionally activated by training and participating in the BLA-GC circuit implicated in learning by prior studies ([@bib25]). Since Fos transcript and protein are short-lived ([@bib74]; [@bib12]), the most parsimonious explanation is that training induces new transcription and translation, and that it is these effects that are disrupted by the Fos KO in BLApn ([Figure 3](#fig3){ref-type="fig"}).

The results of selectively knocking Fos out in BLApn clarify the results of earlier studies in which Fos was manipulated with infusion of antisense oligonucleotides ([@bib38]; [@bib85]) or via global knockout (which had no effect on CTA; [@bib85]). Loss of memory has previously been attributed to inhibition of Fos in central amygdala ([@bib38]), or in the amygdala as a whole along with the GC ([@bib85]). Our demonstration that knockout restricted to BLApn is sufficient to impair memory does not contradict these earlier studies, but suggests that these projection neurons may be a nexus or bottleneck vital for learning in the circuit.

There is still much to be learned about transcription of *Stk11* in CTA. This transcript is presumably less transient than that of immediate early genes, and may be regulated through a process with complex dynamics. This issue is brought into focus by the fact that, across the time points measured, the transcript in profiled cells was decreased, while in anatomically sub-dissected portions of BLA, STK11 protein was increased. Improved temporal and spatial mapping of transcript and protein levels may help clarify these differences.

Regardless, however, the finding that protein levels of STK11 increase are consistent with the fact that *Stk11* deletion before CTA training impairs CTA memory ([Figure 4](#fig4){ref-type="fig"}) and with the finding that Stk11 deletion increases BLApn intrinsic excitability ([Figure 6](#fig6){ref-type="fig"}), which is reduced after CTA training ([Figure 7](#fig7){ref-type="fig"}) and is needed for CTA memory ([Figure 8](#fig8){ref-type="fig"}). Opposing changes in STK11 protein and mRNA levels could reflect homeostatic control of this powerful signaling pathway. Translation-dependent feedback of some other proteins is known to reduce mRNA levels through nonsense-mediated decay ([@bib24]; [@bib59]) or other forms of mRNA degradation ([@bib45]; [@bib73]). Complex feedback control involving changes in RNA export and stability has also been described for MAP kinase signaling ([@bib77]; [@bib62]), but whether this type of regulation exists for *Stk11* and the AMP-related kinase pathway remains unknown. 

Necessity of Stk11 implicates the AMP-related kinase pathway in learning {#s3-2}
------------------------------------------------------------------------

Prior studies of CTA and other forms of aversive learning in the BLA have implicated a number of kinases: including those in the cAMP-dependent protein kinase, protein kinase C, extracellular signal-regulated, and mitogen-activated protein kinase pathways ([@bib31]; [@bib1]). Each of these also have well-established roles in other forms of forebrain learning and plasticity ([@bib2]). Here, we reveal the likely involvement of another kinase cascade, well studied in the contexts of cell growth, metabolism, cancer and polarity ([@bib70]) but hitherto unstudied in the context of learning and memory. That this pathway should have a role in learning is perhaps not shocking given the ubiquity of its previously demonstrated roles in 1) axonal development [@bib7]; [@bib71]; 2) synaptic remodeling during aging [@bib67]; 3) regulation of presynaptic neurotransmission [@bib37]; and perhaps most tellingly 4) regulation of glucose metabolism, feeding and obesity through actions in multiple tissues including hypothalamus ([@bib84]; [@bib18]; [@bib13]). Given the involvement of hypothalamus in coding of taste palatability, and the connectivity between hypothalamus and gustatory cortex ([@bib42]), it is tempting to speculate that the role of Stk11 signaling pathways in feeding may be functionally related to its role in gustatory learning. Further studies will be needed to distinguish whether the involvement of Stk11 in memory is specific to forms of learning regulating consumption, and whether its role in CTA learning is confined to the basolateral amygdala.

STK11 is a master kinase that regulates the activity of 13 downstream AMP-related kinases with diverse roles ([@bib47]). PRKAA1/2 (also known as AMPK) is crucial for metabolic regulation during altered levels of nutrients and intracellular energy. BRSK and MARK regulate cell polarity during development ([@bib7]; [@bib70]). We found that, while *Prkaa1/2* and several other downstream kinase transcripts have low levels of expression in BLApn, others, including *Mark2* and *3*, are expressed at higher levels ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Furthermore, changes in *Mark2* and *Stk11* expression were correlated during CTA learning raising the possibility that both kinases in the pathway contribute to this novel signaling role in learning and memory.

Deletion of Stk11 prior to training profoundly impaired memory, but deletion two days after training---when memory formation and consolidation have already occurred ([@bib2]; [@bib22]; [@bib40]) ---did not. This suggests that Stk11 expression in BLApn promotes memory formation, rather than memory maintenance or retrieval. It is clear that Stk11 deletion left much of the machinery of taste processing and learning intact, however. Activation of Fos by training in the BLA was not impaired after Stk11 deletion, implying that at least the initial stages of transcriptional activation associated with learning are intact. Also left intact was the ability of the BLA to convey palatability information to the GC. Prior studies have shown that silencing of BLA neurons ([@bib60]) impair palatability coding during the late phase of GC gustatory responses. We found that these responses were still present in GC following knockout, implying that this critical function of the BLA for CTA learning remained intact.

Intrinsic excitability of BLApn as a candidate mechanism for Fos and Stk11's effects on CTA memory {#s3-3}
--------------------------------------------------------------------------------------------------

Learning paradigms that support synaptic plasticity also frequently induce changes in neuronal excitability, and such plasticity of intrinsic excitability has long been known to accompany classical conditioning in the neocortex, olfactory cortex, hippocampus, amygdala and cerebellum (for reviews see [@bib90]; [@bib21]; [@bib55]; [@bib78]; [@bib15]).

Although we cannot rule out the possibility that *Stk11* or *Fos* expression in BLApn promotes other forms of plasticity (such as changes in synaptic strength as was suggested in [@bib87]) for *Fos* expression in neurons), our work provide evidence that in BLApn both genes promote changes in intrinsic excitability important for CTA memory. Two genetic manipulations of BLApn that impair learning (deletion of *Stk11* and *Fos*) also increase intrinsic excitability, whereas BLApn involved in normal conditioning appear to undergo the opposite change. Moreover, transiently increasing BLApn intrinsic excitability during training impaired CTA memory, suggesting a model in which *Stk11* and *Fos* promote changes in BLApn intrinsic excitability necessary for CTA memory. This suggests an important role in learning for changes in excitability, and begs the question of mechanism. Although there are likely several such mechanisms, the increase in excitability partly reflects an increase in the resting input resistance and a corresponding decrease in the threshold current needed to evoke firing. It is worth noting that most prior studies of intrinsic plasticity have reported increases in excitability with learning in various brain regions and different animal models ([@bib90]; [@bib55]; [@bib88]; [@bib83]; [@bib10]; [@bib61]). Our results are not without precedent, however; and are similar in polarity to those found in BLApn following olfactory fear conditioning, another form of negative reinforcement learning ([@bib54]). Decreased excitability of Fos-activated neurons was also found using an earlier reporter of Fos promoter activation ([@bib87]).

Although both *Stk11* and *Fos* expression influence BLApn intrinsic excitability, several observations argue this reflects convergence of two at least partially separate signaling pathways in the BLApn neurons. First, deletion of *Stk11* did not block the ability of training to elicit C-FOS expression, and deletion of *Fos* did not block STK11 expression. Additionally, *Stk11* deletion in BLApn had a stronger effect on CTA memory and on intrinsic excitability then deletion of *Fos*. However, our data do not exclude the possibility for synergy between the STK11 and C-FOS signaling pathways. Each signaling pathway could influence excitability by modulating different ion-channels. Alternatively, both signaling pathways may converge on the same ion-channels but influence complementary processes such as expression ([@bib36]), post-translational modification ([@bib82]) or trafficking ([@bib75]). If future studies identify the specific ion channels targeted by STK11 and C-FOS related signaling, these questions of synergy and convergence can be more precisely addressed. Our data do not exclude the possibility that the neurons expressing *Fos* represent a sub-population BLApn expressing *Stk11*. Future studies will be aimed to determine with a much finer resolution the distribution of these genes among the population of BLApn.

In conclusion, our data suggest the following model of CTA ([Figure 9](#fig9){ref-type="fig"}). Training induces the activation of STK11 and C-FOS by increasing their protein levels in BLApn. STK11 activation results in downstream activation (through phosphorylation) of AMP-related kinases, most likely MARK2/3, BRSK2, SIK3, which are abundant in BLApn. C-FOS, an activity dependent transcription factor, induces the transcription of effector genes such as *Nptx2* which is increased following CTA training. NPTX2 may modulate intrinsic excitability through its ability to bind ion-channels ([@bib17]; [@bib11]). The two pathways jointly reduce the intrinsic excitability of BLApn, which plays a key role in gating the formation of CTA memory.

![An integrated model for the formation of CTA memory.\
CTA training mice associate consumption of palatable saccharin with gastric malaise (induced by systemic injection of lithium chloride). Memory formation: CTA training increases the activity STK11 and C-FOS in BLA projection neurons (BLApn) via initially separate signaling pathways. CTA increases STK11 protein but reduces its mRNA, possibly through feedback control. STK11 activation results in downstream phosphorylation and activation of AMP related kinases, likely including Mark2/3, Brsk2, and Sik3, which are abundant in BLApn. C-FOS, an activity dependent transcription factor, induces the transcription of effector genes such as *Nptx2* which increases following CTA training and is known to bind not only ligand-gated receptors, but also voltage-gated ion channels. The two pathways reduce BLApn intrinsic excitability through unknown mechanism(s). CTA retrieval: Reduced BLApn intrinsic excitability plays a key role in CTA memory formation, reducing saccharin consumption in test trials. Blue-behavioral level, Orange-molecular level, Green-cellular level, Red-conditions impairing memory. Dashed line arrows are hypothesized connections.](elife-61036-fig9){#fig9}

Materials and methods {#s4}
=====================

Subjects {#s4-1}
--------

Male and Female mice (total of 209 animals) were used for behavior at age 60--80 days, or for electrophysiology at 25--35 days. Strains: wild-type; WT (C57BL/6J), YFP-H (B6.Cg-Tg(Thy1-YFP)HJrs/J), *Stk11*^f/f^ (B6(Cg)-Stk11tm1.1Sjm/J, Lkb1fl), *Fos*^f/f^ (B6;129-Fostm1Mxu/Mmjax), *Fos-tTA* (B6.Cg-Tg(Fos-tTA,Fos-EGFP\*)1Mmay/J) all purchased from Jackson Laboratories (Bar Harbor, ME). Mice were placed on a 12 hr light-dark cycle, and given ad libitum access to food and water except during training, at which time water access was restricted, while food remained available ad libitum (note that animals reliably consume less food when thirsty). All procedures were approved by the Brandeis University Institutional Animal Care and Use Committee (IACUC, Protocol \#20002) in accordance with NIH guidelines.

Surgery {#s4-2}
-------

### BLA cannulation for RNA synthesis inhibition experiments {#s4-2-1}

WT Mice were anesthetized via ip injections of 100 µg ketamine, 12.5 µg xylazine, 2.5 µg acepromazine per gram (KXA). Guide cannulae (23-gauge, 10 mm length) were implanted above the BLA (mm from bregma, AP = −1.4, DV = 4.2, ML=±3.4; [@bib5]) and stabilized using Vetbond and dental acrylic. Stainless steel stylets (30-gage, 10 mm) were inserted into the guide cannula to ensure patency. Mice received postsurgical metacam (5 µg/g), penicillin (1500 Units/g) and saline (5% bodyweight) per day for three days and recovered a total of 7 days prior to training. Twenty minutes prior to CTA training, mice were infused with either 50 ng of actinomycin-D or vehicle control (PBS) bilaterally (in 1 μl over 2 min) via infusion cannulae extending 0.5 mm below the guide cannulae to reach the BLA. Each cannula was connected to a 10 μl Hamilton syringe on a syringe pump (Harvard Apparatus, MA, USA).

### BLA viral infection {#s4-2-2}

*Stk11*^f/f^, *Fos*^f/f^ and *Fos-tTA* mice were anesthetized with KXA. The skull was exposed, cleaned, and bilateral craniotomies were made at stereotactic coordinates (AP = −1.4, ML=±3.4). BLA were injected bilaterally with AAV2/5-*Camk2α*::Cre-GFP or AAV2/5-*Camk2α*::GFP (UNC, vector core) for *Stk11*^f/f^ and *Fos*^f/f^ mice, *Camk2α*::hM3Dq-mCherry or AAV2/5-Camk2α::GFP (UNC, vector core) for Stk11^f/f^ mice and AAV2/5-TRE::mCherry for Fos-tTa mice, 10 days prior to CTA training using sterile glass micropipettes (10--20 µm diameter) attached to a partially automated microinjection device (Nanoject III Microinjector, Drummond Scientific). The micropipettes were lowered to 4.3 mm and 4.6 mm from the dura to reach the BLA. At each depth, virus (200 nl) was delivered via 10 pulses of 20 delivered every 10 s, with 10 min between each injection. Postsurgical treatment and recovery were as above.

### Conditioned taste aversion (CTA) {#s4-2-3}

Mice were housed individually with free access to food and maintained on a 23.0 hr water deprivation schedule for the duration of training and experimentation. Three days prior to CTA training, water bottles were removed from the cages and water was given twice a day (10 am and six pm) for a duration of 30 min. On the day of CTA mice were given 30 min to consume 0.5% saccharin, which was followed by intraperitoneal (I.P) injection of lithium-chloride (0.15M, 2% of body weight, unless indicated differently) 30 min later. Taste control groups received I.P injection of saline (0.9% sodium chloride) instead of lithium and lithium control group received lithium injection alone 24 hr following Saccharin consumption. CTA testing: Mice were kept on watering schedule twice a day and 48 hr after CTA training mice received CTA testing which consisted of 30 min consumption of 0.5% saccharin. 8 hr following testing mice were given 30 min water consumption.

### Seizure induction {#s4-2-4}

*Fos*^f/f^ mice were housed individually with free access to water and food and received BLA viral infection with Cre and control viruses as described above. After 10 days, mice were injected I.P. with 20 mg/kg kainic acid in PBS. Four hours after injection, mice were perfused for Fos immunohistochemistry.

### CNO treatment {#s4-2-5}

CNO (sigma) was diluted in saline to 1 mg/ml. CNO was systemically injected at a dose of 0.3 mg/kg 1 hr prior to CTA training. We chose this dose as we notice that higher concentration (2 mg/kg) causes seizures as was reported ([@bib4]) and reduction of saccharin consumption. A dose of 0.3 mg/kg did not cause any effect on basal drinking behavior and could strongly activate infected neurons ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}), as reported previously by Alexsander et al.

### Immunohistochemistry {#s4-2-6}

Mice were deeply anesthetized with an overdose of KXA and perfused transcardially with phosphate buffered solution (PBS) followed by 4% paraformaldehyde (PFA). Brains were post-fixed in PFA for 1--2 day, and coronal brain slices (60 µm) containing the BLA (−1 mm to −2.5 mm anterior-poterior axis) were sectioned on a vibratome. Slices were rinsed with PBS and incubated in a blocking solution (PBS/.3%TritionX-100/5% Bovine serum albumin) for 12--24 hr at 4°C. Blocking solution was removed and replaced with the primary antibody solution which consists of 1:100 C-FOS polyclonal rabbit IgG (SC-52G; Santa Cruz Biotechnology) for 24 hr at 4°C. After incubation, slices were rinsed using a PBS/.3% Triton X-100 solution followed by the secondary antibody incubation of 1:500 C-FOS Alexa Flour 546 Goat-Anti-Rabbit IgG (H+L) (Life Technologies) and 5% natural goat serum for 12--24 hr at 4°C. Sections were then rinsed 5--6 times over 90 min (1XPBS/.3% Triton X-100), counterstained with DAPI, mounted with antifade mounting medium (Vectashield), and viewed by confocal fluorescence microscopy (Leica Sp5 Spectral confocal microscope/Resonant Scanner). Imaging and quantification were performed blind to experimental group.

### C-FOS quantification and analysis {#s4-2-7}

To minimize systematic bias, C-FOS counts were performed blind and semi-automatically, using FiJi (University of Wisconsin-Madison; [@bib69]). Eight-bit images were binarized and particles smaller than 10 µm^2^ were rejected. Each cell count was from a separate animal and was the average of counts from six sections through the anterior, middle and posterior regions of the BLA of both hemispheres.

### RNA sequencing experiment {#s4-2-8}

RNA sequencing was performed on YFP^+^ BLApn harvested from male YFP-H mouse line ([@bib19]; [@bib76]; [@bib30]; [@bib52]) which expresses YFP under the Thy1 promoter in the majority of excitatory projection neurons located in the anterior part of the nucleus. The mice underwent CTA training or taste-only controls (n = 4/group) and 4 hr following training were subjected to manual cell-sorting, performed as previously described ([@bib76]; [@bib28]; [@bib72]) by dissociating 150--200 fluorescently labeled neurons in 300-µm-thick brain slices and manually purifying them through multiple transfer dishes with the aid of a pipette viewed under a fluorescence dissection microscope. Total RNA was extracted from sorted cells using Pico-pure RNA isolation kit (Thermo fisher). Amplified cDNA libraries are prepared from isolated, fragmented RNA using the NuGen Ovation RNAseq V.2 kit (NuGEN, San Carlos, CA) and followed by purification using the Beckman coulter Genomic's Agencourt RNA Clean XP kit and Zymo DNA Clean and Concentrator. Sequencing adaptors are ligated per Illumina protocols and 50 bp single-ended reads are obtained from Illumina Hi-Seq machine. Libraries sequenced usually results in 25--30 million unique reads using eightfold multiplexing.

### Analysis {#s4-2-9}

Reads are trimmed and then aligned to the mouse genome using TopHat ([@bib80]). Sam files are converted to binary format using Samtools and visualized at the sequence level using IGV. Script written in python and R statistical package are used to convert unique reads to gene expression values and to filter genes by relative expression and statistical significance. Sequencing data was uploaded to GEO (accession number: GSE138522).

### qPCR validation {#s4-2-10}

The brains of a separate group of YFP-H mice receiving CTA (taste+lithium, N = 4) or taste control (taste+saline, N = 4) were harvested 4 hr following the end of the training and subjected to fax sorting. RNA was extracted using pico-pure kit and reverse transcribed to cDNA using iScript cDNA synthesis kit. qPCR was performed on Rotor-Gene qPCR machine using PCR master mix and transcript-specific sets of primers for *Fos*, *Stk11* as target genes and Snap47 as loading control.

### Acute slice electrophysiology {#s4-2-11}

Ten days after virus injection, acute brain slices were prepared from P28-35 mice. Animals were deeply anesthetized with KXA and transcardially perfused with ice-cold oxygenated cutting solution containing (in mM): 10 N-methyl-D-glucamine (NMDG), 3 KCl, 1 NaH2PO4, 25 NaHCO3, 20 HEPES, 2 Thiourea, 3 Sodium Pyruvate, 12 N-acetyl-L-cysteine, 6 MgCl2, 0.5 CaCl2, 5 Sodium Ascorbate, 10 Glucose (pH: 7.25--7.4, adjusted using HCl). 300 µm coronal slices containing the BLA were cut on a vibratome (Leica), and then recovered for 15 min at 33°C and for 15 min at room temperature in oxygenated recovery solution containing (in mM): 74 NaCl, 3 KCl, 1 NaH~2~PO~4~, 25 NaHCO~3~, 6 MgCl~2~, 0.5 CaCl~2~, 5 Sodium Ascorbate, 75 Sucrose, 10 Glucose, followed by at least another 1 hr at room temperature in oxygenated ACSF containing (in mM): 126 NaCl, 3 KCl, 1 NaH~2~PO~4~, 25 NaHCO~3~, 2 MgCl~2~, 2 CaCl~2~, 10 Glucose. During recordings, slices were perfused with oxygenated 34--35°C ASCF. Target neurons in BLA were identified based on the presence of viral GFP reporter. ACSF included 35 µM d,l-2-amino-5-phosphonovaleric acid (APV) and 20 µM 6,7-dinitroquinoxaline-2,3-dione (DNQX) to block ionotropic glutamate receptors, and 50 µM picrotoxin to block ionotropic GABA receptors. Whole-cell recording pipettes (6--8 MΩ) were filled with internal solution containing (in mM): 100 K-gluconate, 20 KCl, 10 HEPES, 4 Mg-ATP, 0.3 Na-GTP, 10 Na-phosphocreatine, and 0.1% biocytin. Recordings were amplified (Multiclamp 700B, Molecular Devices) and digitized at 10 kHz using a National Instruments Board under control of IGOR Pro (WaveMetrics). Resting membrane potentials were adjusted to −70 mV and steady state series resistance was compensated. Series resistance and input resistance were calculated using −5 mV (voltage clamp) or 25 pA (current clamp) seal tests before each trial of recording. Measurements of input resistance in Fos reporter labeled neurons ([Figure 7](#fig7){ref-type="fig"}) were measured in voltage clamp, all other recordings were performed in current clamp. The calculated liquid junction potential (−10 mV) was compensated post hoc. Neurons with high series resistance (\>30 MΩ current clamp) or membrane potentials that changed by \>10 mV were excluded. Hyperpolarization activated sag was measured from responses to −100 pA current steps. Action potential (AP) threshold, amplitude, afterhyperpolarization (AHP) and full width at half-height were averaged from the 5th-10th APs in trials with 10 to 20 Hz firing rates. AP threshold is the membrane potential at which the slope first exceeds 10 V/s, and AP amplitude was measured relative to threshold. Sag ratio is defined as the fraction by which the membrane potential depolarized at steady-state from its maximum hyperpolarization during a −100 pA current step. Medium AHP was measured as the peak hyperpolarization after the APs mentioned above relative to threshold. The slow AHP was measured from the peak hyperpolarization following positive current steps generating 10--20 Hz firing.

In vivo recording of GC taste responses {#s4-3}
---------------------------------------

### Surgery {#s4-3-1}

*Stk11*^f/f^ mice were anesthetized and prepared for stereotaxic surgery and viral infection as above. Each mouse was also implanted bilaterally with multi-channel electrode bundles (16 formvar-coated, 25 µm diameter nichrome wires) in GC (Distance from Bregma: AP=+1.2 mm; ML = ± 3 mm; DV of −2.25 mm from the *pia mater*) and a single intraoral cannula (IOC; flexible plastic tubing) was inserted into the cheek to allow controlled delivery of taste stimuli. 24 hr before recording sessions began electrode bundles were then further lowered by 0.75--1.00 mm to reach ventral GC (see [Figure 5A](#fig5){ref-type="fig"}).

### IOC fluid delivery protocol {#s4-3-2}

Experiments began with three days of habituation to the recording setup and to receiving liquid through the IOC. Sixty 15 µl aliquots (hereafter, 'trials') of water were delivered across 30 min. To ensure adequate hydration, mice were given two 30 min period of access to additional water.

On the following day, recording commenced and water trials were replaced with four different taste stimuli: sweet (0.2 M sucrose), salty (0.1 M sodium chloride), sour (0.02 M citric acid), and bitter (0.001 M quinine). A total of 15 trials were delivered for each taste in random order. These tastes and concentrations were chosen because they provided a broad range of hedonic values for palatability assessment. Fluid delivery through a nitrogen-pressurized system of polyethylene tubes was controlled by solenoid valves via a Raspberry Pi computer (construction details and code available on request from \[<https://github.com/narendramukherjee/blech_clust>\] [@bib56]; copy archived at <https://github.com/elifesciences-publications/blech_clust>\]).

### Taste palatability coding {#s4-3-3}

To determine whether a neuron displays palatability activity, we performed a moving window analysis (window size: 250 ms; step size: 25 ms) to trace the dynamics of taste processing in GC. For each time window, we calculated a Spearman product-moment correlation between the ranked firing rates to each taste and the palatability rankings obtained previously in separate experiments ([@bib41]).

Research resource identifiers (RRIDs) {#s4-4}
-------------------------------------

### Software {#s4-4-1}

1.  TopHat, RRID:[SCR_013035](https://scicrunch.org/resolver/SCR_013035);

2.  Samtools, RRID:[SCR_002105](https://scicrunch.org/resolver/SCR_002105); IGV, RRID:[SCR_011793](https://scicrunch.org/resolver/SCR_011793); IGOR Pro, RRID:[SCR_000325](https://scicrunch.org/resolver/SCR_000325); Fiji, RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285).

### Antibodies {#s4-4-2}

1.  FOS-Santa Cruz Biotechnology Cat\# sc-52, RRID:[AB_2106783](https://scicrunch.org/resolver/AB_2106783).

2.  FOS- Santa Cruz Biotechnology Cat\# sc-166940, RRID:[AB_10609634](https://scicrunch.org/resolver/AB_10609634).

3.  STK11-Millipore Cat\# 09--495, RRID:[AB_10807178](https://scicrunch.org/resolver/AB_10807178);

4.  STK11-Sigma-Aldrich Cat\# SAB4502888 RRID:[AB_10746328](https://scicrunch.org/resolver/AB_10746328)

5.  Alexa Fluor 647 Goat Anti-Rabbit IgG (H+L)- Thermo Fisher Scientific Cat\# A-21245, RRID:[AB_2535813](https://scicrunch.org/resolver/AB_2535813).

### Viruses {#s4-4-3}

1.  AAV-CaMKIIa-GFP-Cre; AAV-CaMKIIa-EYFP and AAV-CamkIIa-hM3Dq-mCherry, (AAV5)-UNC Joint Vector Laboratories, RRID:[SCR_002448](https://scicrunch.org/resolver/SCR_002448).

### Mice strains {#s4-4-4}

1.  Wild type-RRID:[IMSR_JAX:000664](https://scicrunch.org/resolver/IMSR_JAX:000664); YFP-H (B6.Cg-Tg(Thy1-YFP)HJrs/J)- RRID:[IMSR_JAX:003782](https://scicrunch.org/resolver/IMSR_JAX:003782);

2.  *Stk11*^f/f^ (B6(Cg)-Stk11tm1.1Sjm/J, Lkb1fl)- RRID:[IMSR_JAX:014143](https://scicrunch.org/resolver/IMSR_JAX:014143).

3.  *Fos*^f/f^ (B6;129-Fostm1Mxu/Mmjax)- RRID:[MMRRC_037115-JAX](https://scicrunch.org/resolver/MMRRC_037115-JAX).

4.  *Fos-tTA* (B6.Cg-Tg(Fos-tTA,Fos-EGFP\*)1Mmay/J)- RRID:[IMSR_JAX:018306](https://scicrunch.org/resolver/IMSR_JAX:018306).

Statistical analysis {#s4-5}
--------------------

The results are expressed as means ± s.e.m unless otherwise stated. All effects were evaluated using either paired t-test or one- or two-way ANOVA test with post hoc t-tests corrected (Bonferroni) for all possible pair-wise comparisons. Two-way mixed ANOVAs were performed using a mixture of between-subjects and repeated-measures factors depending on the design (e.g. repeated measures for multiple current injections to the same neurons in [Figures 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}). No power analysis was performed and numbers of replicates performed were the minimum needed to demonstrate reproducibility, consistent with practices in similar published studies.
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**Acceptance summary:**

The underlying cellular and molecular mechanisms of long-lasting taste aversive memory are not well elucidated. This manuscript tackles this issue by using a multi-level approach combining large scale gene expression profiling, gene knockouts, physiology, and manipulation of neuronal activity with a behavioral model of conditioned taste aversion. This study demonstrates that specific molecules involved in neuronal activity, in basolateral amygdala neurons that send axons to other brain regions, are important for the long-term memory of taste aversion.

**Decision letter after peer review:**

\[Editors' note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.\]

Thank you for submitting your work entitled \"Deletion of Stk11 and Fos BLA projection neurons alters intrinsic excitability and impairs formation of aversive memory\" for consideration by *eLife*. Your article has been reviewed by a Senior Editor, a Reviewing Editor, and three reviewers. The following individuals involved in review of your submission have agreed to reveal their identity: A.J. Robison (Reviewer \#1); Shauna L Parkes (Reviewer \#3).

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

There was agreement that the results would be of interest for the readers of *eLife*, but the major concerns noted by the reviewers require additional work that is beyond the scope of the time scale for revision for *eLife*. Given the enthusiasm for the study, if you are able to address each of the reviewers\' concerns, we would be willing to reconsider your manuscript as a new submission. The major concerns regarded the lack of a cohesive story and a clear model, and the statistical analyses. These are detailed in the reviews below. In their discussion, the reviewers noted suggestions for the revision that could help to provide a clear model. It was suggested to examine whether the KO of one gene changes expression of the other gene to determine if c-Fos or Stk11 is the upstream molecule. A further suggestion was to perform a double knockout study to determine if this is additive for or occludes excitability. Overall, additional work would be needed to cohesively convey the message that learning requires gene expression and that this gene expression is involved in regulating BLA neuron excitability.

Reviewer \#1:

The manuscript \"Deletion of Stk11 and Fos BLA projection neurons alters intrinsic excitability and impairs formation of aversive memory\" uses a combination of mouse behavior, molecular biology, pharmacology, genetic manipulation, and electrophysiology to uncover a novel role for the kinase Stk11 in the function of BLA projection neurons and their role in aversive learning. The experimental approach is strong and well thought out, and the findings are mostly robust and consistent. The lack of an overall model and incomplete interpretation is a major concern, and there are a few minor concerns with terminology.

Essential revisions:

1\) There is a logical disconnect between the gene expression findings and the electrophysiological findings. After learning, c-Fos and Stk11 are oppositely regulated in the BLA: cFos is increased and Stk11 is decreased (Figure 2). However, knocking out either gene increases the excitability of the neurons (Figure 6 and Figure 7). Since the authors attempt to connect excitability directly to learning (Figure 7E), this is difficult to parse. If learning decreases excitability, that fits with the induction of cFos, but not with the decrease in Stk11. The authors should attempt to address this apparent discrepancy in the Discussion and propose a model that takes all of these data into account.

2\) The potential conflicting expression data for cFos and Stk11 bring up another issue: are these changes in gene expression occurring in the same cells? One possible explanation for the apparent contradiction in point 1 above is that cFos is induced in a separate population of BLA cells from those in which Stk11 is decreased. Is it possible to determine whether this cell population is the same?

Reviewer \#2:

The manuscript reports on the role of Fos and Stk11 in conditioned taste aversion learning (CTA). The study focuses on projection neurons in the basolateral nucleus of the amygdala (BLApn), which is known to contribute to CTA learning. Using RNA-seq the authors identify a number of genes that are upregulated or downregulated following CTA. They choose to focus on Fos, previously shown to increase in BLA following CTA, and Stk11, a kinase that contributes to a variety of cellular functions but has not been studies in the context of learning. CTA increases Fos expression in BLA projection neurons (as previously shown) and decreases Stk11 mRNA levels. However, the level of expression of Stk11 protein is increased following CTA indicating complexity in the signaling underlying this form of aversive learning. Using a loss of function approach, the authors show that loss of Fos has a minimal effect on CTA, while loss of Slk11 impairs learning. Additional experiments examine the effect of loss of function on BLApn excitability and examine palatability coding in the gustatory cortex (GC), which receives a prominent projection from BLA and is involved in CTA learning. While the results are interesting, the study suffers from lack of clarity and several inconsistencies in the approach and results.

Essential revisions:

1\) The Abstract, Introduction and Results section lack consistency. The Abstract seems to indicate that the target of the study is Stk11 and its signaling and that CTA learning is a model of learning to investigate the molecule. Differently, the Introduction seems to indicate that CTA is the main subject and that the authors aim to investigate the cellular mechanisms for CTA. Finally, in the Results section the initial setup is to show that CTA requires protein synthesis and RNA-seq is used to identify potential targets. Across all sections the choice to focus on Stk11 is never justified, leaving the reader wondering why this molecule and not another one of the \>30 identified by RNA-seq.

2\) The authors interpret the impaired CTA in loss of Stk11 function experiments as indicative of an increase in the expression of the gene during CTA training. However, their results indicate that Stk11 mRNA levels decrease following CTA, therefore a loss of Stk11 would be expected to induce CTA, not prevent it. On the other hand, Stk11 protein levels increase following CTA, suggesting that it is protein synthesis, not gene expression that contributes to CTA.

3\) The Fos loss of function experiment also shows some inconsistency across results. Fos increases following CTA, thus one may expect that preventing this increase would prevent CTA if Fos expression is necessary for learning. However, the results reported here show only a minor effect on CTA magnitude, suggesting that the increase in Fos expression plays a minor effect in this form of aversive learning.

4\) The connection between CTA, gene expression and neuronal excitability is rather weak and indirect. If the increase in Fos is prevented neurons become more excitable, which is in contrast with the idea that Fos is induced by neuronal activation. As CTA is still induced in these conditions, the relationship between Fos, learning and neuronal excitability is unclear. In the case of Stk1, loss of function also increases excitability, but in this case there is no CTA.

5\) The palatability data from GC in the Stk11 KO model are also hard to interpret. Previous data by the Katz lab showed that spiking activity of GC neurons is altered following CTA. As a loss of function in BLA Stk11 mimics the effect of CTA, one would expect that the Stk11-KO alone would alter GC activity in the palatability epoch. However, the data show otherwise, suggesting that Stk11 signaling may not be sufficient for altering palatability coding in GC. While from the signaling perspective this is an interesting finding, it is hard to reconcile with the other components of this study.

Reviewer \#3:

Levitan and colleagues explore the role of the kinase Stk11 in aversive learning. I enjoyed reading this manuscript. The authors have made a considerable effort to carefully control their experiments, provide some specificity to the effect of Stk11 deletion as well as provide a potential mechanism (intrinsic BLApn excitability) for their findings. Briefly, the authors report that new transcription in the BLA is required for CTA learning and such learning causes changes in the expression of the kinase Stk11 in BLA projection neurons. Conditional Stk11 knockout in BLApn during (but not after) taste-LiCl pairings blocks learning and also increases the excitability of BLA projection neurons. This change in excitability did not appear to alter the ability of the BLA-GC circuit to respond to gustatory stimuli. These data are particularly exciting as Stk11 has not previously been implicated in learning. I believe that this manuscript is worthy of publication in *eLife* but have a few concerns that should be addressed.

1\) Figure caption 3: Could the authors please clarify the statistics reported for panel C. The authors state N=8 per group (and two groups: GFP and CRE) so a total of 16 mice. However, the df for the genotype main effect (GFP vs CRE) is reported as (1,28). I don\'t understand how 28 is calculated for 16 animals and 2 between-subjects groups. In addition, in subsection "Fos and Stk11 expression in BLA projection neurons are necessary for memory formation", it is stated that \"Post hoc analysis (Bonferroni) revealed that both GFP (n=8) and Cre (N=8) group reductions following CTA (test vs. train) were significant but differences between other groups were not.\" What are these other groups? Were there initially other groups involved in this experiment? If so, I\'m wondering if that might also explain the somewhat surprising significant interaction reported in (C). Finally, on Figure 3C, N=8 is labeled for each column giving the impression that the \"train\" and \"test\" conditions were not the same animals. I imagine that the N should only be reported on the \"train\" column, as in Figure 4A and 4D.

2\) Subsection "Stk11 deletion does not impact basal aspects of taste behavior" -- It wasn\'t immediately clear to me what \"behavior\" referred to in this experiment. It seems that \"behavior\" is the GC neurons responses rather than the behavior of the mice, is that correct? Indeed, if I understood correctly, in this manuscript, there was no behavioral measurement of palatability (e.g., licking microstructure, number of licks etc). However, if this is the case, to what does \"the behaviorally-determined palatability ranking\" refer? Does it refer to another data set that was previously reported (Levitan et al., 2019), as stated? If so, can the authors please justify the use of behavioral data from another set of mice (perhaps already published) to calculate the correlations (between firing rates and behaviorally measured palatability) reported in Figure 5.

3\) Could the authors please provide a brief justification for using only the taste only control (and not the LiCl control) in the majority of experiments?

4\) Introduction: \"Not known to play a role in learning or the regulation of intrinsic neuronal excitability\" It is unclear from this sentence if the authors mean that the role of Stk11 in learning/neuronal excitability has not previously been studied or if it has been studied and no evidence was found for an involvement in these processes.

10.7554/eLife.61036.sa2

Author response

\[Editors' note: the authors resubmitted a revised version of the paper for consideration. What follows is the authors' response to the first round of review.\]

> The major concerns regarded the lack of a cohesive story and a clear model, and the statistical analyses. These are detailed in the reviews below. In their discussion, the reviewers noted suggestions for the revision that could help to provide a clear model. It was suggested to examine whether the KO of one gene changes expression of the other gene to determine if c-Fos or Stk11 is the upstream molecule. A further suggestion was to perform a double knockout study to determine if this is additive for or occludes excitability. Overall, additional work would be needed to cohesively convey the message that learning requires gene expression and that this gene expression is involved in regulating BLA neuron excitability.

We have taken the reviewers' and editors' suggestion to examine whether knockout of one gene changes expression of the other. We find that *Stk11* KO animals can still upregulate C-FOS expression to a similar degree and that STK11 expression is unaltered in the *Fos* KO animals (Figure 5---figure supplement 1). We conclude, that at least at the level of *Stk11* and *Fos* themselves, the genes are not upstream or downstream of one another and separately feed into mechanisms of neuronal excitability and learning. We have not ruled out possible interactions of downstream portions of the signaling cascade and make this clear in the manuscript.

We have not performed the double knockout study for several reasons. First, we calculated that it would require close to a year of additional breeding since it would require mice that carry 5 alleles (two of each knockout, plus the cre-dependent reporter) and such mice are impossible to achieve in one generation and are more likely to require 3 or 4 generations or more. Second, and perhaps more importantly, we are not convinced it would be informative. Since the blockade of learning in the case of the *Stk11* knockout is essentially complete, it would be very difficult to quantitatively distinguish between additive and occlusive phenotypes. The *Fos* KO produces a less complete blockade of learning, but in either an additive (independent pathways) or occlusive (same pathway) model, the observed effect of the double KO would be increased relative to the *Fos* KO and unchanged relative to the *Stk11* KO.

Finally, we have revised the statistical approach as suggested.

Specific replies to all of the issues raised by each of the reviewers are given below.

In a nutshell, the new data and model address the reviewer's concerns and comments specifically regarding:

1\) Potential interactions between *Stk11* and *Fos*. Figure 5---figure supplement 1 shows evidence for the lack of interaction between *Fos* and *Stk11* signaling pathways. subsection "*Fos* and *Stk11* expression in BLA projection neurons are necessary for memory formation", Subsection "Intrinsic excitability of BLApn as a candidate mechanism for Fos and Stk11's effects on CTA memory.

2\) Causal relation between CTA memory formation and BLApn intrinsic excitability. Figure 8 (including Figure 8---figure supplement 1) shows the causal relation between CTA memory formation and BLApn intrinsic excitability. Subsection "*Stk11* and *Fos* deletion increase the intrinsic excitability of BLApn, while CTA decreases excitability", Subsection "Necessity of Stk11 implicates the AMP-related kinase pathway in learning".

3\) A clear model that describes the ways *Stk11* and *Fos* signaling pathways effects memory formation through their modulation of intrinsic excitability. A new figure (Figure 9) now summarizes our model for the roles of Stk11, Fos and intrinsic excitability in the formation of CTA memory. Subsection "*Stk11* and *Fos* deletion increase the intrinsic excitability of BLApn, while CTA decreases excitability"; subsection "Intrinsic excitability of BLApn as a candidate mechanism for Fos and Stk11's effects on CTA memory.".

> Reviewer \#1:
>
> The manuscript \"Deletion of Stk11 and Fos BLA projection neurons alters intrinsic excitability and impairs formation of aversive memory\" uses a combination of mouse behavior, molecular biology, pharmacology, genetic manipulation, and electrophysiology to uncover a novel role for the kinase Stk11 in the function of BLA projection neurons and their role in aversive learning. The experimental approach is strong and well thought out, and the findings are mostly robust
>
> and consistent.

Thank you for highlighting positive features of the manuscript.

> The lack of an overall model and incomplete interpretation is a major concern, and there are a few minor concerns with terminology.

In our revised manuscript we added new experiments and analyses and provide a model summarized diagrammatically (Figure 9) and explained in the Discussion section. The question of terminology is addressed below.

> Essential revisions:
>
> 1\) There is a logical disconnect between the gene expression findings and the electrophysiological findings. After learning, c-Fos and Stk11 are oppositely regulated in the BLA: cFos is increased and Stk11 is decreased (Figure 2). However, knocking out either gene increases the excitability of the neurons (Figure 6 and Figure 7). Since the authors attempt to connect excitability directly to learning (Figure 7E), this is difficult to parse. If learning decreases excitability, that fits with the induction of cFos, but not with the decrease in Stk11. The authors should attempt to address this apparent discrepancy in the Discussion and propose a model that takes all of these data into account.

The reviewer is absolutely correct that levels of *Stk11* transcript decline at the time point measured, however we also found that levels of protein were increased at the same time point. We appreciate the suggestion of presenting a model of how this might occur and have tried to do so both in the discussion and schematically in Figure 9. Although *Stk11* mRNA decreases following CTA training (Figure 2B and C) protein levels increase (Figure 2---figure supplement 2). Although discrepancies between measurement of RNA and protein expression are unusual, they do occur. Such discrepancies would be expected if activation of Stk11 led to feedback inhibition of subsequent transcription or to enhanced mRNA degradation. These types of negative feedback have been described for other genes, a point we now discuss subsection "BLA projection neurons undergo transcription important for CTA learning". We are actively pursuing the question of whether and how this feedback occurs, but this is likely to require a significant body of new experiments which we feel are better left for a follow up paper.

The finding that protein levels of STK11 increase are consistent with the fact that *Stk11* deletion before CTA training impairs CTA memory (Figure 4). The finding that *Stk11* deletion increases BLApn intrinsic excitability (Figure 6) is consistent with the reduction in intrinsic excitability evident after CTA training (Figure 7) and with the fact that increasing excitability using *hM3Dq* DREADD impairs CTA memory (Figure 8). This logic is now discussed in the text (subsection "BLA projection neurons undergo transcription important for CTA learning") and diagrammed in Figure 9. Subsection "*Stk11* and *Fos* deletion increase the intrinsic excitability of BLApn, while CTA decreases excitability"; subsection "Intrinsic excitability of BLApn as a candidate mechanism for Fos and Stk11's effects on CTA memory.".

> 2\) The potential conflicting expression data for cFos and Stk11 bring up another issue: are these changes in gene expression occurring in the same cells? One possible explanation for the apparent contradiction in point 1 above is that cFos is induced in a separate population of BLA cells from those in which Stk11 is decreased. Is it possible to determine whether this cell population is the same?

The issue brought up by the reviewer is interesting and important, however a complete cellular map of changes in the expression of *Fos* and *Stk11* transcript and protein is beyond the scope of this manuscript. *Stk11* is ubiquitously expressed both in humans and in mice (see e.g. https://www.tau.ac.il/\~elieis/HKG/HK_genes.txt and in situ hybridization for this gene in the Allen Brain Atlas). Hence it is likely that cells activating *Fos* represent a subset of the cells activating *Stk11*. Future studies will aim to determine with a much finer resolution the distribution of these genes among the population of BLApn.

> Reviewer \#2:
>
> The manuscript reports on the role of Fos and Stk11 in conditioned taste aversion learning (CTA). The study focuses on projection neurons in the basolateral nucleus of the amygdala (BLApn), which is known to contribute to CTA learning. Using RNA-seq the authors identify a number of genes that are upregulated or downregulated following CTA. They choose to focus on Fos, previously shown to increase in BLA following CTA, and Stk11, a kinase that contributes to a variety of cellular functions but has not been studies in the context of learning. CTA increases Fos expression in BLA projection neurons (as previously shown) and decreases Stk11 mRNA levels. However, the level of expression of Stk11 protein is increased following CTA indicating complexity in the signaling underlying this form of aversive learning. Using a loss of function approach, the authors show that loss of Fos has a minimal effect on CTA, while loss of Slk11 impairs learning. Additional experiments examine the effect of loss of function on BLApn excitability and examine palatability coding in the gustatory cortex (GC), which receives a prominent projection from BLA and is involved in CTA learning. While the results are interesting, the study suffers from lack of clarity and several inconsistencies in the approach and results.
>
> Essential revisions:
>
> 1\) The Abstract, Introduction and Results section lack consistency. The Abstract seems to indicate that the target of the study is Stk11 and its signaling and that CTA learning is a model of learning to investigate the molecule. Differently, the Introduction seems to indicate that CTA is the main subject and that the authors aim to investigate the cellular mechanisms for CTA.

We thank the reviewer for pointing out that our argument was not as clearly presented as it should have been. We have rewritten portions of the Abstract, Introduction and Results section to attempt to clarify the essential argument made succinctly in our title. The molecular and cellular mechanisms of CTA within the BLA are our primary interest. The focus on *Fos* and *Stk11* and the way the two sets of results are balanced reflect the following important considerations:

1\) *Fos* is known to be activated during learning and to be important for CTA specifically, hence the fact that *Fos* changes in expression is an important positive control but is not in and of itself of immediate general interest.

2\) *Stk11* and the AMP-related kinase signaling pathway are highly studied (2755 and 18,635 pubmed entries respectively) and have broad significance outside of neuroscience but have not previously been implicated in learning. Demonstration that the master kinase in this pathway is important for CTA learning is an important new result and hence is emphasized.

3\) Uniquely, among the genes identified, *Fos* and *Stk11* have existing conditional alleles that allow local, conditional knockout specifically within BLA projection neurons. This is a far more powerful approach for investigating gene function in learning than other more partial or more global approaches.

4\) Surprisingly, both genes appear to have similar effects on BLApn excitability, leading us to focus on this cellular context for their molecular actions, and strengthening the importance of considering both genes in the paper. We have now added results that show that manipulating excitability of these neurons independently of either gene also blocks learning and have shown that the two genes independently converge on excitability since knocking out one does not affect expression of the other.

We feel that although it is more complex to include manipulations of two genes and cellular and behavioral analyses in the paper, the story is greatly enriched by this inclusion. We have tried to make the essential logic clearer with changes to the Abstract, Introduction, Results section, Discussion section and a new figure diagramming our model, but we welcome additional suggestions as to how we could further clarify the choice of genes to investigate, or other aspects of our argument.

> Finally, in the results section the initial setup is to show that CTA requires protein synthesis and RNA-seq is used to identify potential targets. Across all sections the choice to focus on Stk11 is never justified, leaving the reader wondering why this molecule and not another one of the \>30 identified by RNA-seq.
>
> 2\) The authors interpret the impaired CTA in loss of Stk11 function experiments as indicative of an increase in the expression of the gene during CTA training. However, their results indicate that Stk11 mRNA levels decrease following CTA, therefore a loss of Stk11 would be expected to induce CTA, not prevent it. On the other hand, Stk11 protein levels increase following CTA, suggesting that it is protein synthesis, not gene expression that contributes to CTA.

The initial portion of the results demonstrate that new transcription, and not only new protein synthesis are required. That new protein synthesis is required for CTA was previously known, but here we show for the first time that CTA also requires new transcription.

For a gene to affect learning it must both be transcribed and translated. We do not know that new transcription of *Stk11* is required for learning and the discussion makes note of this fact (subsection "BLA projection neurons undergo transcription important for CTA learning"). We were indeed surprised to find that the transcript and protein levels of *Stk11* are discordant at the time point measured. We have added this point to our discussion and included it in our model. We are actively investigating the biological basis of this unusual regulation. Nevertheless, the increased levels of protein are quite consistent with the fact that loss of the gene blocks learning.

> 3\) The Fos loss of function experiment also shows some inconsistency across results. Fos increases following CTA, thus one may expect that preventing this increase would prevent CTA if Fos expression is necessary for learning. However, the results reported here show only a minor effect on CTA magnitude, suggesting that the increase in Fos expression plays a minor effect in this form of aversive learning.
>
> 4\) The connection between CTA, gene expression and neuronal excitability is rather weak and indirect. If the increase in Fos is prevented neurons become more excitable, which is in contrast with the idea that Fos is induced by neuronal activation. As CTA is still induced in these conditions, the relationship between Fos, learning and neuronal excitability is unclear. In the case of Stk1, loss of function also increases excitability, but in this case there is no CTA.

Genes differ in their degree of penetrance with respect to many phenotypes, including complex phenotypes like learning. The effect of *Fo*s knockout on learning is smaller in amplitude than that observed for *Stk11*, but the results are robust (2-fold increase in the fraction of Saccharin consumed vs. a 2.4 fold increase for *Stk11*) and reproducible (significant interaction between genotype and training). We do not see differences in penetrance as a concern but suggest that *Stk11* and *Fos* effect BLApn intrinsic excitability (and thus memory) by different signaling pathways and mechanisms. This is further reinforced by new results showing that *Fos* cKO does not effect STK11 expression and that *Stk11* cKO does not affect C-FOS expression (Figure 5---figure supplement 1). This is presented and discussed in: Subsection "*Fos* and *Stk11* expression in BLA projection neurons are necessary for memory formation", subsection "Intrinsic excitability of BLApn as a candidate mechanism for Fos and Stk11's effects on CTA memory".

Additionally, we do not claim to have ruled out the possibility that one or both genes also affect behavior through additional mechanisms that do not depend on changes in excitability (subsection "Necessity of Stk11 implicates the AMP-related kinase pathway in learning").

Finally, we have directly tested the relationship between learning and neuronal excitability using chemogenetic manipulation of excitability independently of manipulating either signaling pathway. These results (Figure 8 and Figure 8---figure supplement 1) make a stronger argument for causal involvement in learning of changes in excitability. Subsection "*Stk11* and *Fos* deletion increase the intrinsic excitability of BLApn, while CTA decreases excitability"; subsection "Necessity of Stk11 implicates the AMP-related kinase pathway in learning".

> 5\) The palatability data from GC in the Stk11 KO model are also hard to interpret. Previous data by the Katz lab showed that spiking activity of GC neurons is altered following CTA. As a loss of function in BLA Stk11 mimics the effect of CTA, one would expect that the Stk11-KO alone would alter GC activity in the palatability epoch. However, the data show otherwise, suggesting that Stk11 signaling may not be sufficient for altering palatability coding in GC. While from the signaling perspective this is an interesting finding, it is hard to reconcile with the other components of this study.

The reviewer is correct that if KO of *Stk11* produced the identical effects to those of learning, a change in GC activity in the palatability epoch would be expected. However, we do not suggest that KO of *Stk11* mimics learning. For example, the two have opposite effects on BLApn intrinsic excitability: learning decreases, while *Stk11* KO increases excitability. We were worried that *Stk11* KO might have other baseline effects on sensory processing or on the ability of BLApn to respond to training by transcriptionally activating C-FOS. If either the baseline coding or ability to become activated during training were impaired, this might explain the learning phenotype. Instead, our results show that cKO of *Stk11* does not affect GC coding of taste palatability at baseline (Figure 5) and that KO neurons in the BLA can still respond to training by activating C-FOS (Figure 5-figure supplement 1). Together, these results argue that *Stk11* is important for CTA memory formation, rather than for the initial ability of the system to respond to conditioned and unconditioned stimuli. This idea is also supported by the fact that *Stk11* KO does not influence CTA retrieval (Figure 4D).

> Reviewer \#3:
>
> Levitan and colleagues explore the role of the kinase Stk11 in aversive learning. I enjoyed reading this manuscript. The authors have made a considerable effort to carefully control their experiments, provide some specificity to the effect of Stk11 deletion as well as provide a potential mechanism (intrinsic BLApn excitability) for their findings. Briefly, the authors report that new transcription in the BLA is required for CTA learning and such learning causes changes in the expression of the kinase Stk11 in BLA projection neurons. Conditional Stk11 knockout in BLApn during (but not after) taste-LiCl pairings blocks learning and also increases the excitability of BLA projection neurons. This change in excitability did not appear to alter the ability of the BLA-GC circuit to respond to gustatory stimuli. These data are particularly exciting as Stk11 has not previously been implicated in learning. I believe that this manuscript is worthy of publication in eLife but have a few concerns that should be addressed.

Thank you for appreciating the positive aspects of our study.

> 1\) Figure caption 3: Could the authors please clarify the statistics reported for panel C. The authors state N=8 per group (and two groups: GFP and CRE) so a total of 16 mice. However, the df for the genotype main effect (GFP vs CRE) is reported as (1,28). I don\'t understand how 28 is calculated for 16 animals and 2 between-subjects groups. In addition, in subsection "Fos and Stk11 expression in BLA projection neurons are necessary for memory formation", it is stated that \"Post hoc analysis (Bonferroni) revealed that both GFP (n=8) and Cre (N=8) group reductions following CTA (test vs. train) were significant but differences between other groups were not.\" What are these other groups? Were there initially other groups involved in this experiment? If so, I\'m wondering if that might also explain the somewhat surprising significant interaction reported in (C). Finally, on Figure 3C, N=8 is labeled for each column giving the impression that the \"train\" and \"test\" conditions were not the same animals. I imagine that the N should only be reported on the \"train\" column, as in Figure 4A and 4D.

We revised all statistical analysis in the manuscript including Figure 3. For example, for Figure 3 we now report F(1,14). The degrees of freedom is 14 reflecting the 16 animals in two groups. The reviewer is correct that there are no other groups and that we were incorrect and unclear in referring to other conditions as if they were groups. This is corrected in the figure, legend and corresponding text. The interaction reported in C is expected since although both genotypes (control GFP and Cre knockout) have a reduction following training, the reduction is larger in the control animals than in the knockout, hence there is an interaction between training and genotype. We have clarified the labeling of N in Figure 3 as requested.

> 2\) Subsection "Stk11 deletion does not impact basal aspects of taste behavior" -- It wasn\'t immediately clear to me what \"behavior\" referred to in this experiment. It seems that \"behavior\" is the GC neurons responses rather than the behavior of the mice, is that correct? Indeed, if I understood correctly, in this manuscript, there was no behavioral measurement of palatability (e.g., licking microstructure, number of licks etc).

The reviewer is correct. We have corrected this misstatement by changing the sentence to:

"*Stk11* deletion in BLApn does not impact taste palatability coding in the GC" subsection "*Fos* and *Stk11* expression in BLA projection neurons are necessary for memory formation".

> However, if this is the case, to what does \"the behaviorally-determined palatability ranking\" refer? Does it refer to another data set that was previously reported (Levitan et al., 2019), as stated? If so, can the authors please justify the use of behavioral data from another set of mice (perhaps already published) to calculate the correlations (between firing rates and behaviorally measured palatability) reported in Figure 5.

The reviewer is correct. We used the palatability rankings of four taste stimuli (sucrose, sodium chloride, citric acid and quinine) previously determined by us in a recent study in mice (Levitan et al., 2019). This ranking is highly robust and has been repeated in other studies in mice (Fletcher et al., 2017; Lavi et al., 2018) and rats (Katz et al., 2001; Piette et al., 2002). The use of a nonparametric rank correlation ensures that the results are robust despite variations in absolute firing rates or preferences across animals. We refined this point in the methods section and in the Figure legend. subsection "*Stk11* deletion in BLApn does not impact taste palatability coding in the GC", subsection "*In-vivo recording of GC taste responses"*.

> 3\) Could the authors please provide a brief justification for using only the taste only control (and not the LiCl control) in the majority of experiments?

A single control condition consisting of the taste stimulus without the unconditioned stimulus was used in the screening experiments of Figure 1 and Figure 2 (and associated supplements) since our principle aim was to identify target genes that could then be tested for causal roles in learning in subsequent behavioral experiments. A prior study from the Rosenblum lab (Rappaport et al., 2015) used a microarray screen following CTA to show that LiCl treatment (compared to taste control treatment) induced more than half of the same genes induced by CTA treatment (compared to taste control treatment). We have now made this point clear in the text. subsection "Transcripts regulated in BLA projection neurons following CTA".

> 4\) Introduction: \"Not known to play a role in learning or the regulation of intrinsic neuronal excitability\" It is unclear from this sentence if the authors mean that the role of Stk11 in learning/neuronal excitability has not previously been studied or if it has been studied and no evidence was found for an involvement in these processes.

We meant the former. We have clarified this by changing the wording to: "it has not previously been studied in the context of learning and memory or in the regulation of intrinsic neuronal excitability."

[^1]: These authors contributed equally to this work.
